Since January 2020 Elsevier has created a COVID - 19 resource centre with free information in English and Mandarin on the novel coronavirus COVID - 19 . The COVID - 19 resource centre is hosted on Elsevier Connect , the company ' s public news and information website . Elsevier hereby grants permission to make all its COVID - 19 - related research that is available on the COVID - 19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories , such as the WHO COVID database with rights for unrestricted research re - use and analyses in any form or by any means with acknowledgement of the original source . These permissions are granted for free by Elsevier for as long as the COVID - 19 resource centre remains active . Journal Pre - proof Predictors and microbiology of respiratory and bloodstream bacterial infection in patients with COVID - 19 : living rapid review update and meta - regression Bradley J . Langford , BScPhm , PharmD , Miranda So , BScPhm , PharmD , MPH , Valerie Leung , BScPhm , MBA , Sumit Raybardhan , BScPhm , MPH , Jennifer Lo , BScPhm , PharmD , Tiffany Kan , BScPhm , PharmD , Felicia Leung , HBSc , Duncan Westwood , BA , Nick Daneman , MD , MSc , Derek R . MacFadden , MD , ScD , Jean - Paul R . Soucy , MSc PII : S1198 - 743X ( 21 ) 00636 - 4 DOI : https : / / doi . org / 10 . 1016 / j . cmi . 2021 . 11 . 008 Reference : CMI 2748 To appear in : Clinical Microbiology and Infection Received Date : 30 August 2021 Revised Date : 27 October 2021 Accepted Date : 5 November 2021 Please cite this article as : Langford BJ , So M , Leung V , Raybardhan S , Lo J , Kan T , Leung F , Westwood D , Daneman N , MacFadden DR , Soucy J - PR , Predictors and microbiology of respiratory and bloodstream bacterial infection in patients with COVID - 19 : living rapid review update and meta - regression Clinical Microbiology and Infection , https : / / doi . org / 10 . 1016 / j . cmi . 2021 . 11 . 008 . This is a PDF file of an article that has undergone enhancements after acceptance , such as the addition of a cover page and metadata , and formatting for readability , but it is not yet the definitive version of record . This version will undergo additional copyediting , typesetting and review before it is published in its final form , but we are providing this version to give early visibility of the article . Please note that , during the production process , errors may be discovered which could affect the content , and all legal disclaimers that apply to the journal pertain . Crown Copyright Â© 2021 Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases . All rights reserved . 1 Predictors and Microbiology of Respiratory and Bloodstream Bacterial Infection in Patients with COVID - 19 : Living Rapid Review Update and Meta - Regression Bradley J Langford , BScPhm , PharmD 1 , 2 Miranda So , BScPhm , PharmD , MPH 3 , 4 , 5 Valerie Leung , BScPhm , MBA 1 , 6 Sumit Raybardhan , BScPhm , MPH 7 Jennifer Lo , BScPhm , PharmD 8 Tiffany Kan , BScPhm , PharmD 6 Felicia Leung , HBSc 4 Duncan Westwood , BA Nick Daneman , MD , MSc 1 , 4 , 8 , 10 , 11 Derek R MacFadden , MD , ScD 12 Jean - Paul R Soucy , MSc 9 1 . Public Health Ontario , ON , Canada 2 . Hotel Dieu Shaver Health and Rehabilitation Centre , ON , Canada 3 . Sinai Health - University Health Network Antimicrobial Stewardship Program , University Health Network , Toronto , Canada 4 . University of Toronto , ON , Canada 5 . Toronto General Hospital Research Institute , Toronto , ON , Canada 6 . Toronto East Health Network , Michael Garron Hospital , ON Canada 7 . North York General Hospital , ON , Canada 8 . Sunnybrook Health Sciences Centre , ON , Canada 9 . Division of Epidemiology , Dalla Lana School of Public Health , University of Toronto , ON , Canada 10 . Sunnybrook Research Institute , ON , Canada 11 . ICES ( formerly Institute for Clinical Evaluative Sciences ) , ON Canada 12 . Ottawa Hospital Research Institute , ON , Canada J o u r n a l P r e - p r o o f 2 Objective : To identify risk factors and microbiology associated with respiratory and bloodstream bacterial infection in patients with COVID - 19 . Methods : Data Sources : We searched MEDLINE , OVID Epub and EMBASE for published literature up to February 5 , 2021 . Study eligibility criteria : Studies including at least 50 patients with COVID - 19 in any healthcare setting . Assessment of risk of Bias : We used a validated 10 - item risk of bias tool for disease prevalence Methods of data synthesis : The main outcome of interest was the proportion of COVID - 19 patients with bloodstream and / or respiratory bacterial co - infection and secondary infection . We performed meta - regression to identify study population factors associated with bacterial infection including healthcare setting , age , comorbidities and COVID - 19 medication . Results : Out of 33 , 345 studies screened , 171 were included in the final analysis . Bacterial infection data were available from 171 , 262 patients . The prevalence of co - infection was 5 . 1 % ( 95 % CI : 3 . 6 % to 7 . 1 % ) and secondary infection was 13 . 1 % ( 95 % CI : 9 . 8 % to 17 . 2 % ) . There was a higher odds of bacterial infection in studies with a higher proportion of patients in the intensive care unit ( ICU ) ( adjusted OR 18 . 8 , 95 % CI : 6 . 5 to 54 . 8 ) . Female sex was associated with a lower odds of secondary infection ( adjusted OR 0 . 73 , 95 % CI : 0 . 55 to 0 . 97 ) but not co - infection ( adjusted OR 1 . 05 , 95 % CI : 0 . 80 to 1 . 37 ) . The most common organisms isolated included Staphylococcus aureus , coagulase - negative Staphylococci , and Klebsiella species . Conclusions : While the odds of respiratory and bloodstream bacterial infection are low in patients with COVID - 19 , meta - regression revealed potential risk factors for infection , including ICU setting and mechanical ventilation . The risk for secondary infection is substantially greater than the risk for co - infection in patients with COVID - 19 . Understanding predictors of co - infection and secondary infection may help to support improved antibiotic stewardship in patients with COVID - 19 . Registration : PROSPERO ( ID CRD42021241098 ) . J o u r n a l P r e - p r o o f 3 Introduction There is rising concern about the long - term impact of COVID - 19 on antimicrobial resistance . While bacterial co - infection rates in patients presenting with COVID - 19 have been found to be low ( < 5 % ) ( 1 , 2 ) , the majority ( 50 - 75 % ) of hospitalized patients with COVID - 19 receive antibiotics ( 3 , 4 ) . The rates of secondary bacterial infection , those that occur later on in illness , tend to be higher ( 10 - 20 % ) , but are typically related to healthcare - associated infections involving invasive devices , such as ventilators and central venous access ( 1 , 5 , 6 ) . There are limited data describing the causative pathogens and their susceptibility patterns among COVID - 19 patients with bacterial co - infections . Despite the low rate of infection early in illness , a large observational study found that 57 % of patients with COVID - 19 received early empiric antibiotics and 46 % of these patients had their antibiotics continued after a positive COVID - 19 PCR test . Of those who had antibiotics continued despite no confirmed bacterial infection , 64 % had antibiotics continued for five or more days ( 3 ) . The vast discrepancy between the rate of proven bacterial infection and antibiotic use suggests an urgent need for antimicrobial stewardship . However , there are several diagnostic challenges that drive antibiotic overuse in COVID - 19 , most notably the difficulties in 1 ) differentiating viral from bacterial infection prior to the COVID - 19 test result , and 2 ) definitively ruling out bacterial co - infection in those after a positive COVID - 19 test . A better understanding of the population - level predictors of bacterial co - infection and secondary infection can help identify situations where antibiotics are more likely to provide benefit , and uncover opportunities for antimicrobial stewardship . Additionally , a characterization of the common organisms identified in early versus late bacterial infection in a COVID - 19 patient may help clinicians optimize prescribing , particularly regarding when and which empiric treatment may be beneficial . As the standard of care for COVID - 19 infection evolved rapidly over the course of the pandemic , including the life - saving measures of respiratory support and use of immunotherapy based on emerging evidence , it was deemed important to update our analysis reflecting this change in practice . Our objective was to build J o u r n a l P r e - p r o o f 4 upon our previously published rapid review to describe the prevalence and microbiological characteristics of respiratory and bloodstream co - infection and secondary infection and to use meta - regression to identify study - level predictors of bacterial infections in patients with COVID - 19 . Methods We conducted a rapid systematic review guided by the Cochrane Rapid Reviews Methods Group ( 7 ) to evaluate concomitant bacterial infection in patients with COVID - 19 . We included studies of humans with COVID - 19 , across all healthcare settings ( i . e . , hospital , community , long - term care ) , and age groups ( pediatric and adult patients ) . We included cohort studies , case series with 50 or more patients and randomized controlled trials that did not evaluate antibiotic use as an intervention , but excluded reviews , editorials , letters , and case studies . We excluded studies that 1 ) included patients with non - laboratory - proven COVID - 19 , 2 ) tested for co - infection using only nasopharyngeal swabs , 3 ) did not differentiate between bacterial infection and other co - infections or secondary infections ( e . g . , fungal ) , 4 ) indicated bacterial infection was presumed or suspected ( e . g . , use of white blood cell count , biomarkers ) , and 5 ) used serology as a bacterial infection diagnostic approach . This protocol was registered under PROSPERO , the international registry of systematic reviews ( ID CRD42021241098 ) . Data Sources We performed systematic searches of MEDLINE , OVID Epub , and EMBASE databases for published literature in any language from January 1 , 2019 to February 5 , 2021 with assistance from a medical library information specialist . The expanded timeline aimed to capture new publication since the systematic search we performed for our earlier review ( January 1 , 2019 to April 16 , 2020 ) ( 8 ) . The current search was structured to include COVID - 19 terms co - infection , bacterial infection , respiratory infection , epidemiology , or descriptive cohort study terms . The complete search strategy is described in the Online Supplement . The results of the search were J o u r n a l P r e - p r o o f 5 imported into Covidence ( Covidence , Melbourne , Australia ) , an online software tool for systematic reviews . Duplicate records were removed using Covidence . Study Selection Initial screening of titles and abstracts from the search were shared by two authors ( BL or VL ) , who independently identified studies that met all inclusion criteria and none of the exclusion criteria . All full text studies meeting initial criteria were then reviewed by one of the authors ( BL , MS , VL , SR , TK , JL , or DM ) for final inclusion in the rapid review . Single screening was utilized given the high volume of citations and the substantial kappa agreement ( 0 . 62 to 0 . 68 ) from our team for previous rapid reviews in which duplicate screening was performed ( 9 ) . Data Extraction One of seven authors ( BL , MS , VL , SR , TK , JL , or DM ) independently extracted data from included studies using a standardized data collection form . For quality assurance , one of three authors ( FL , VL or BL ) then verified all extracted data to confirm accuracy and completeness . We collected data on the following variables for demographics and setting : author ; country of study ; start and end dates ; study design ; healthcare setting ( inpatient ICU vs . non ICU , outpatient ) ; sample size ; age group ; patient population ; mean or median age ; and number of female patients . Regarding clinical characteristics , we collected information on COVID - 19 severity ; number of patients requiring mechanical ventilation ; number of patients that were smokers ; number of patients with comorbidities ( chronic obstructive pulmonary disease , cardiovascular disease , or diabetes ) ; and number of patients who were prescribed corticosteroids , interleukin - 6 ( IL - 6 ) inhibitors ( i . e . , tocilizumab or sarilumab ) , and antibacterial agents . We extracted respiratory and bloodstream microbiology data , including specimen source and identification , if the information was available . Assessment of Bias We used a validated 10 - item risk of bias tool for disease prevalence ( 10 ) . Risk of bias was categorized as low ( score â¥ 8 ) , moderate ( score 5 - 7 ) , or high ( score 0 - 4 ) . A sensitivity analysis J o u r n a l P r e - p r o o f 6 was performed stratifying proportion of bacterial infection by study risk of bias . Additional sensitivity analyses were performed to 1 ) remove studies where bacteriological testing method and bacterial infection source were not specified and 2 ) to stratify studies based on whether they used a clinical definition for bacterial infection ( e . g . , differentiated infection from colonization or contamination using clinical criteria ) . Data Synthesis The main outcome of interest was the overall prevalence of respiratory and bloodstream bacterial co - infection or secondary infection among patients with COVID - 19 . We evaluated the number of patients developing a bacterial infection at any point during the course of their illness while under study observation as a proportion of all patients with COVID - 19 . First , studies were categorized based on whether they evaluated co - infection ( authors used the term co - infection and / or specified that infection was assessed on admission or at the time of health care visit ) , secondary infection ( authors used the term secondary infection , super - infection , healthcare - associated infection , and / or indicated that infection was identified > 48 hours after initial assessment ) . Studies that did not specify co - infection or secondary infection were grouped with co - infection . To estimate overall bacterial infection , for studies reporting both co - infection and secondary infection , we selected the higher proportion of the two . Second , the source of infection was categorized as respiratory , bloodstream , both respiratory and bloodstream , or not specified . Infections specified from other sources ( e . g . , urine , skin ) were not included . For the purposes of this study , both co - infection and secondary infection were limited to respiratory and / or bloodstream specimens to estimate the prevalence of infections closely linked to COVID - 19 while limiting bias due to variability in diagnosis of other less relevant conditions ( e . g . , skin and soft tissue infections and urinary tract infections ) . Third , studies were categorized based on the bacteriological testing method ( culture , nucleic acid amplification , a combination of approaches , or not specified ) . J o u r n a l P r e - p r o o f 7 We pooled proportion data across studies via a random - effects meta - analysis using a generalized linear mixed model ( GLMM ) with logit link approach ( 11 , 12 ) . Results were illustrated using forest plots stratified by healthcare setting and infection type . Heterogeneity was assessed by I 2 statistic ( 13 ) . All analyses were carried out using R version 4 . 1 . 1 with the packages metafor and meta . The statistical code for this analysis is made available online ( 14 ) . Meta - regression To predict the effect of specific population - level variables on bacterial infection , we performed univariable meta - regression evaluating patient characteristics ( age , sex , comorbidities , use of medication for treatment of COVID - 19 ) , markers of severity ( e . g . , mechanical ventilation ) , healthcare setting , geographic region ( Asia , Middle East , Europe , North America , South America ) , and end - month of study . Differences in prevalence of antibiotic prescribing for each variable were described in terms of the prevalence odds ratio ( OR ) compared to reference , per 10 % increase for continuous variables and per 10 year increase for age . Multi - variable meta - regression was then performed to account for key factors mediating the risk of infection including mean / median patient age ( 15 ) and severity of COVID - 19 ( an index including the highest value of : % of patients with ARDS ; % of ICU patients ; % of mechanical ventilation patients ) ( 16 ) . One model per variable was constructed , and only studies where both the variable of interest and the adjustment variables were reported were included . We used the same subset of studies with available data for both the unadjusted and adjusted analyses . Given studies that did not report whether they evaluated co - infection vs . secondary infection were grouped with co - infection , a sensitivity analysis was performed to remove these studies with unspecified outcome to determine the robustness of our findings . J o u r n a l P r e - p r o o f 8 Results Of 56 , 767 studies identified via searching , after duplicate removal , we reviewed a total of 33 , 345 studies via title and abstract screening , 1 , 798 of which were assessed via full - text screening . We included 171 studies in the final analysis ( 3 , 17 â 185 ) ( Figure 1 ) . Study design was primarily retrospective in nature ( n = 149 ) , with fewer prospective cohorts ( n = 19 ) , or randomized controlled trials ( n = 3 ) . COVID - 19 study data was collected from December 2019 to October 2020 . Study Geography The majority of studies took place in Europe ( 67 , 39 % ) , followed by Asia ( 55 , 32 % ) , North America ( 34 , 20 % ) , Middle East ( 10 , 6 % ) , South and Central America ( 3 , 2 % ) , and multiple regions ( 2 , 1 % ) . Healthcare Setting Most studies took place in a general hospital setting ( 129 , 75 % ) , followed by only intensive care unit ( ICU ) patients ( 33 , 19 % ) , mixed hospitalized patients and outpatients ( 9 , 5 % ) , and a single study limited to outpatients ( 1 , 1 % ) . Patient Characteristics A total of 171 , 262 patients were evaluated for bacterial infection across the 171 studies . A median 41 % of participants were female ( interquartile range ( IQR ) 33 to 48 % ) . The median age was 61 years ( IQR 53 to 64 , range 5 to 85 ) . Only four studies included a population with a median age less than 18 years . Studies included a median of 25 % ICU patients ( IQR 13 to 100 % ) and a median of 21 % ( IQR 10 to 52 % ) patients receiving mechanical ventilation . Smokers comprised a median of 9 % ( IQR 5 to 22 % ) of the study populations . Common comorbidities included chronic respiratory disease ( median 6 % , IQR 4 to 12 % ) , cardiovascular disease ( median 14 % , IQR 6 to 20 % ) , and diabetes ( median 21 % , IQR 12 to 32 % ) . Bacterial Infection Assessment in COVID - 19 J o u r n a l P r e - p r o o f 9 Most studies did not specify how bacterial infection was detected ( 82 , 48 % ) , followed by studies using culture methods ( 72 , 42 % ) , combined approach using culture with nucleic acid amplification and / or urinary antigen testing ( 16 , 9 % ) , and nucleic acid amplification alone ( 1 , 1 % ) . Sources assessed for infection included a combination of respiratory and bloodstream isolates ( 75 , 44 % ) , respiratory only ( 38 , 22 % ) , blood only ( 22 , 13 % ) , and unclear site of infection ( 35 , 20 % ) . The minority of studies ( 66 , 39 % ) employed a clinical definition for diagnosis of bacterial infection . A total of 86 studies ( 59 explicitly used co - infection terminology , and 27 not specified ) including 137 , 325 patients evaluated for co - infection , and 95 studies including 40 , 843 patients evaluated for secondary infection . This includes ten studies that assessed patients for both co - infection and secondary infection . Microbiological Characteristics of Bacterial Infections in COVID - 19 A total of 76 studies specified organism identification for bacterial infections ( co - infections n = 1 , 319 and secondary infections n = 2 , 016 ) . For co - infections , the most common bacterial organisms identified included Staphylococcus aureus ( S . aureus ) ( 332 , 25 % ) , coagulase - negative Staphylococcus ( CNST ) ( 217 , 16 % ) , and Klebsiella species ( 113 , 9 % ) . For secondary infections , identified organisms were more diverse but the most common organisms were similar including S . aureus ( 315 , 16 % ) and Klebsiella species ( 233 , 11 % ) . Figure 2 contains complete details for all organisms identified . Prevalence of Bacterial Infection in Patients with COVID - 19 When pooling bacterial infection across all 171 , 262 patients with COVID - 19 , the prevalence of overall respiratory and / or bloodstream bacterial infection was 8 . 8 % ( 95 % CI : 6 . 9 to 11 . 1 % ) . Bacterial co - infection occurred in 5 . 1 % ( 95 % CI : 3 . 6 to 7 . 1 % ) of patients and increased with the level or intensity of care , from mixed hospital / outpatient populations ( 1 . 9 % , 95 % CI : 0 . 5 to 7 . 1 % ) , to hospitalized patients ( 4 . 4 % , 95 % CI : 3 . 0 to 6 . 4 % ) , to intensive care only ( 15 . 4 % , 95 % CI : 10 . 5 to 22 . 0 % ) . Secondary bacterial infection was more common at 13 . 1 % ( 95 % CI : 9 . 8 % to 17 . 2 % ) . While mixed hospital / outpatient populations ( 11 . 1 % , 95 % CI : 1 . 4 to 52 . 3 % ) and hospitalized populations ( 8 . 2 % , 95 % CI : 6 . 3 to 10 . 7 % ) experienced a lower risk of secondary infection , secondary bacterial infection was more common in ICU populations ( 41 . 9 % , 95 % CI : J o u r n a l P r e - p r o o f 10 29 . 5 to 55 . 4 ) . The degree of heterogeneity in the prevalence of bacterial co - infection and secondary infection was substantial ( I 2 = 98 % ) . See Figure 2 . The prevalence of bacterial infection differed depending on the site of infection reported : respiratory and blood isolates ( co - infection 6 . 2 % , 95 % CI : 3 . 6 to 10 . 5 % ; secondary infection : 16 . 3 % , 11 . 9 to 22 . 0 % ) , blood alone ( co - infection 6 . 0 % , 95 % CI 3 . 4 to 10 . 3 % ; secondary infection : 10 . 7 % , 95 % CI 3 . 4 to 28 . 8 % ) , and respiratory isolates alone ( co - infection 2 . 9 % , 95 % CI 1 . 6 to 4 . 9 % ; secondary infection 12 . 2 % , 95 % CI : 4 . 9 to 27 . 1 % ) . See Figure 3 . Meta - Regression - Predictors of Co - Infection and Secondary Infection in COVID - 19 COVID - 19 co - infection rates were higher in studies with a higher proportion of ICU patients ( adjusted OR 6 . 96 , 95 % CI : 2 . 14 to 22 . 65 ) and secondary infection ( adjusted OR 32 . 10 , 95 % CI : 2 . 66 to 387 . 30 ) compared to those not admitted to an ICU . Studies with a higher proportion of mechanically ventilated patients were associated with a greater odds of both co - infection ( adjusted OR 1 . 24 , 95 % CI : 1 . 11 to 1 . 40 ) and secondary infection ( adjusted OR 1 . 44 , 95 % CI : 1 . 32 to 1 . 57 ) . Advanced study population age did not appear to be associated with a greater odds of co - infection ( adjusted OR 1 . 06 , 95 % CI : 0 . 87 to 1 . 28 per 10 year increase ) or secondary infection ( adjusted OR 1 . 24 , 95 % CI : 0 . 93 to 1 . 66 per 10 year increase ) . Higher proportion of female patients appeared to be protective for secondary infection ( adjusted OR 0 . 73 , 95 % CI : 0 . 55 to 0 . 97 ) but not co - infection ( adjusted OR 1 . 05 , 95 % CI 0 . 80 to 1 . 37 ) . There was no association between the proportion of study corticosteroid use and bacterial infections ( co - infection : adjusted OR 1 . 07 , 95 % CI : 0 . 88 to 1 . 29 , secondary infection : adjusted OR 0 . 99 , 95 % CI : 0 . 87 to 1 . 12 ) or IL - 6 inhibitor use ( co - infection : adjusted OR 1 . 06 , 95 % CI 0 . 85 to 1 . 31 , secondary infection : adjusted OR 0 . 98 , 95 % CI : 0 . 87 to 1 . 10 ) and bacterial infection in patients with COVID - 19 . ( Table 1 ) . Sensitivity Analyses Although the overall estimate of bacterial infection was similar when stratified by study risk of bias , studies with a moderate risk of bias reported numerically higher rates of bacterial infections in ICU patients ( 44 . 2 % , 95 % CI 28 . 8 to 60 . 8 ) , compared to the same population in J o u r n a l P r e - p r o o f 11 studies with high ( 18 . 8 % , 95 % CI : 13 . 9 to 25 . 0 % ) and low risk of bias ( 24 . 5 % , 95 % CI : 15 . 2 % to 36 . 9 % ) ( Supplementary Figure 1 ) . However , this difference was not statistically significant upon meta - regression in either unadjusted or adjusted analyses . Studies with a high risk of bias had a greater odds of co - infection ( adjusted OR 2 . 45 , 95 % CI : 1 . 05 to 5 . 72 ) but not secondary infection ( adjusted OR 0 . 67 , 95 % CI : 0 . 26 to 1 . 71 ) ( Table 1 ) . Estimates of proportion of bacterial infection were similar when removing studies where bacteriological testing method and bacterial infection source were not specified ( Supplementary Figure 2 ) . Studies that employed a clinical definition for bacterial infection appeared to report similar prevalence of infection compared to those without this definition ( Supplementary Figure 3 ) . When removing studies that did not explicitly state whether they evaluated co - infection vs . secondary infection , the findings were similar , with one key exception . ICU setting did not appear to be associated with co - infection risk after removing these studies ( adjusted OR 3 . 61 95 % CI 0 . 46 to 28 . 36 ) ; however , the association between ICU setting and secondary infection risk persisted , adjusted OR 32 . 10 ( 95 % CI 2 . 66 to 387 . 30 ) . Antibiotic Prescribing in Patients with COVID - 19 Out of 31 , 802 patients evaluated for antibiotic prescribing , the prevalence of antibiotic use in patients with COVID - 19 was 76 . 2 % ( 95 % CI : 67 . 3 to 83 . 2 % ) . There did not appear to be an appreciable change in prescribing over time during the period January to September 2020 . There was substantial heterogeneity between studies in the prevalence of antibiotic prescribing ( I 2 = 99 % ) ( Supplementary Figure 4 ) . J o u r n a l P r e - p r o o f 12 Discussion We previously conducted a rapid review / meta - analysis on the prevalence of bacterial co - infection and another on the antibiotic prescribing based on literature published in the first few months of the pandemic ( 1 , 4 ) . The current update included literature published up to the beginning of February 2021 â over a year since SARS - CoV - 2 was first identified . In this analysis , the pooled estimated prevalence of bacterial co - infection in 5 . 1 % , and increased with the severity of COVID - 19 infection . The prevalence of secondary infections was estimated to be 13 % , more than double that of co - infection . With meta - regression , this updated analysis provides a more comprehensive and granular picture on the predictors of bacterial infections in COVID - 19 while confirming our earlier findings . Furthermore , compared to pandemic influenza which has been associated with a risk of bacterial co - infection of at least 19 % ( 186 , 187 ) , the risks of bacterial co - infection and secondary infections from SARS - CoV - 2 appear to be lower . A series of pivotal studies established two classes of immunotherapy , systemic corticosteroids and IL - 6 inhibitors , as standards of care for patients with moderate to severe acute respiratory distress syndrome requiring hospitalization requiring respiratory support ( 188 â 191 ) . Given their immunomodulatory effects , concern has been raised regarding their role in secondary infections in COVID - 19 . Our analyses did not identify a significantly higher odds of secondary bacterial infections among patients exposed to corticosteroids or IL - 6 inhibitors . These findings may reflect the fact that other drivers , such as the inflammatory response to SARS - CoV - 2 and invasive devices , are more significant contributing factors of bacterial infections in patients with COVID - 19 ( 192 ) and as such there may be limited benefit of empiric antibiotics in the absence of proven infection for patients receiving these agents . Alternatively , our study may not be adequately powered to detect the impact of these immunomodulatory agents on secondary infections , given the relatively low rate of bacterial infection events . The most common organisms identified in patients with both co - infection and secondary infection are S . aureus , CNST , and Klebsiella species . These pathogens reflect those seen in hospital - acquired pneumonia and bloodstream infections also seen outside of the context of J o u r n a l P r e - p r o o f 13 COVID - 19 ( 193 , 194 ) . However , given most studies did not attempt to differentiate infection from contamination , CNST may represent contamination in many cases ( 174 ) . At 77 % , the prevalence of antibiotic prescribing was high and incongruent with the relatively low prevalence of bacterial infections . This outcome remained consistent with our previous publication ( 4 ) . Of note , clinical guidelines for COVID - 19 recommendations varied with respect to the use of empiric antibiotics , particularly in critically ill patients ( 195 â 198 ) . Differences in the recommended approach to antibiotic prescribing may explain why the use of antibiotics remained higher than prevalence of bacterial infections . Our findings support a more judicious approach , particularly in patients outside of the ICU . A limitation of this review is that these findings are constrained by the quality of the underlying primary literature , as less than one third of included studies were considered to be at low risk of bias . We also noted a high degree of heterogeneity across studies , of which it is not clear whether this reflects a difference in clinical characteristics , diagnostic approaches , and / or clinical practice across settings . However , our findings are relatively consistent across study risk of bias rating and align with those in recent large high - quality observational cohort studies ( 83 , 161 ) . A second limitation is our focus on microbiological identification of bacterial infection . There may be a risk of under - estimating the true prevalence of co - infection and secondary infection given that only a proportion of patients receive microbiological testing to confirm the presence of bacterial infection . On the other hand , a microbiological definition alone may overestimate infection in the setting of colonization without evidence of a true respiratory infection . Finally , the distinction between bacterial co - infection and secondary infection is not always consistent across the literature ( 199 ) . Terms may be used interchangeably or not at all , leading to a risk of misclassification bias . To address this risk , we reported both an estimate of co - infection and secondary infection , as well as overall bacterial infection , the latter of which reduces the impact of imprecision associated with terminology chosen by study authors . Over a year into the pandemic , these findings provide further supporting evidence for the relatively low rate of bacterial infection in COVID - 19 and may serve an impetus for J o u r n a l P r e - p r o o f 14 antimicrobial stewardship initiatives , such as risk stratification for early empiric antibiotics , and early discontinuation in patients with COVID - 19 and lack of confirmed concomitant bacterial infection . Conclusion While the odds of respiratory and bloodstream bacterial infection are low in patients with COVID - 19 , potential risk factors for infection include ICU setting and mechanical ventilation . The risk for secondary infection is substantially greater than the risk for co - infection in patients with COVID - 19 . Antibiotics appear to continue to be over - prescribed in COVID - 19 . Understanding predictors of co - infection and secondary infection may help to support improved antibiotic stewardship in patients with COVID - 19 . J o u r n a l P r e - p r o o f 15 Conflicts The authors have no conflicts of interest to declare . Author Contributions Concept and design : All authors . Acquisition , analysis , or interpretation of data : All authors . Drafting of the manuscript : Langford , So Critical revision of the manuscript for important intellectual content : All authors . Statistical analysis : Soucy , Langford Administrative , technical , or material support : All authors . Funding : This project was carried out as part of routine work . Additional Contributions The authors would like to thank : Ashley Farrell , BA , MLIS , AHIP , Information Specialist for her support with formulating and executing the search strategy for this review . Parmvir Parmar MD , FRCPC for his support in full text screening for this review . We thank the Toronto Antimicrobial Resistance Research Network ( TARRN ) , an inter - professional forum of clinicians and researchers that acted as a venue for bringing together this research team , and a repository for our rapid review . J o u r n a l P r e - p r o o f 16 Table 1 . Study - Level Predictors of Bacterial Co - infection , Secondary Infection and Overall Bacterial Infection in Patients with COVID - 19 ( Prevalence Odds Ratio , 95 % CI ) Characteristic Co - infection ( n = 86 ) Secondary infection ( n = 95 ) Bacterial infection ( n = 171 ) # Studies Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted Overall Setting ( reference = Hospital / Outpatient ) Reference Reference Reference Reference Reference Reference 8 Hospital 1 . 74 ( 0 . 64 to 4 . 71 ) 1 . 49 ( 0 . 54 to 4 . 12 ) 3 . 53 ( 0 . 28 to 44 . 19 ) 4 . 16 ( 0 . 36 to 48 . 82 ) 2 . 89 ( 1 . 07 to 7 . 78 ) 2 . 31 ( 0 . 86 to 6 . 24 ) 120 ICU 8 . 40 ( 2 . 65 to 26 . 65 ) 6 . 96 ( 2 . 14 to 22 . 65 ) 28 . 63 ( 2 . 22 to 369 . 50 ) 32 . 10 ( 2 . 66 to 387 . 30 ) 24 . 79 ( 8 . 57 to 71 . 74 ) 18 . 83 ( 6 . 48 to 54 . 77 ) 32 Study end month ( reference = Jan to May 2020 ) Reference Reference Reference Reference Reference Reference 134 Jun to Oct 2020 1 . 66 ( 0 . 53 to 5 . 15 ) 1 . 28 ( 0 . 48 to 3 . 44 ) 1 . 14 ( 0 . 43 to 2 . 98 ) 1 . 14 ( 0 . 54 to 2 . 41 ) 1 . 48 ( 0 . 67 to 3 . 25 ) 1 . 18 ( 0 . 63 to 2 . 20 ) 19 Region ( reference = North America ) Reference Reference Reference Reference Reference Reference 29 Europe 1 . 35 ( 0 . 57 to 3 . 20 ) 1 . 03 ( 0 . 48 to 2 . 18 ) 1 . 81 ( 0 . 76 to 4 . 34 ) 1 . 46 ( 0 . 72 to 2 . 96 ) 1 . 68 ( 0 . 82 to 3 . 41 ) 1 . 28 ( 0 . 72 to 2 . 27 ) 62 Asia 0 . 96 ( 0 . 39 to 2 . 36 ) 1 . 51 ( 0 . 67 to 3 . 41 ) 0 . 69 ( 0 . 27 to 1 . 76 ) 0 . 99 ( 0 . 46 to 2 . 12 ) 0 . 80 ( 0 . 38 to 1 . 69 ) 1 . 18 ( 0 . 64 to 2 . 18 ) 49 Middle East 0 . 98 ( 0 . 14 to 7 . 05 ) 2 . 39 ( 0 . 37 to 15 . 39 ) 0 . 70 ( 0 . 17 to 2 . 90 ) 0 . 66 ( 0 . 21 to 2 . 08 ) 0 . 96 ( 0 . 27 to 3 . 39 ) 1 . 01 ( 0 . 36 to 2 . 85 ) 8 South and Central America 1 . 52 ( 0 . 20 to 11 . 45 ) 2 . 04 ( 0 . 35 to 11 . 82 ) 2 . 37 ( 0 . 11 to 49 . 18 ) 0 . 71 ( 0 . 06 to 8 . 03 ) 1 . 31 ( 0 . 19 to 9 . 07 ) 1 . 07 ( 0 . 22 to 5 . 13 ) 3 Multiple 11 . 08 ( 0 . 84 to 145 . 78 ) 3 . 81 ( 0 . 39 to 37 . 42 ) 0 . 03 ( 0 . 00 to 0 . 92 ) 0 . 08 ( 0 . 00 to 1 . 30 ) 0 . 67 ( 0 . 07 to 6 . 94 ) 0 . 47 ( 0 . 07 to 3 . 13 ) 2 Risk of bias ( reference = Low ) Reference Reference Reference Reference Reference Reference 52 Moderate 1 . 17 ( 0 . 59 to 2 . 33 ) 1 . 57 ( 0 . 87 to 2 . 86 ) 1 . 20 ( 0 . 58 to 2 . 49 ) 1 . 02 ( 0 . 58 to 1 . 79 ) 1 . 22 ( 0 . 69 to 2 . 15 ) 1 . 20 ( 0 . 76 to 1 . 89 ) 82 High 1 . 72 ( 0 . 64 to 4 . 61 ) 2 . 45 ( 1 . 05 to 5 . 72 ) 0 . 60 ( 0 . 18 to 2 . 00 ) 0 . 67 ( 0 . 26 to 1 . 71 ) 0 . 91 ( 0 . 38 to 2 . 15 ) 1 . 13 ( 0 . 57 to 2 . 26 ) 19 Age ( 10 - year increase ) 1 . 20 ( 0 . 97 to 1 . 48 ) 1 . 06 ( 0 . 87 to 1 . 28 ) 1 . 53 ( 1 . 07 to 2 . 18 ) 1 . 24 ( 0 . 93 to 1 . 66 ) 1 . 37 ( 1 . 12 to 1 . 69 ) 1 . 12 ( 0 . 94 to 1 . 34 ) 153 % Female ( 10 % increase ) 0 . 74 ( 0 . 58 to 0 . 93 ) 1 . 05 ( 0 . 80 to 1 . 37 ) 0 . 50 ( 0 . 37 to 0 . 67 ) 0 . 73 ( 0 . 55 to 0 . 97 ) 0 . 58 ( 0 . 47 to 0 . 71 ) 0 . 87 ( 0 . 71 to 1 . 07 ) 152 % Mech . ventilation ( 10 % increase ) 1 . 26 ( 1 . 13 to 1 . 41 ) 1 . 24 ( 1 . 11 to 1 . 40 ) 1 . 45 ( 1 . 33 to 1 . 58 ) 1 . 44 ( 1 . 32 to 1 . 57 ) 1 . 42 ( 1 . 32 to 1 . 53 ) 1 . 41 ( 1 . 30 to 1 . 52 ) 124 % Smoker ( 10 % increase ) 0 . 89 ( 0 . 58 to 1 . 37 ) 0 . 72 ( 0 . 46 to 1 . 14 ) 0 . 85 ( 0 . 52 to 1 . 37 ) 0 . 79 ( 0 . 55 to 1 . 12 ) 0 . 89 ( 0 . 63 to 1 . 27 ) 0 . 73 ( 0 . 54 to 0 . 98 ) 58 % COPD ( 10 % increase ) 1 . 02 ( 0 . 55 to 1 . 90 ) 0 . 86 ( 0 . 49 to 1 . 51 ) 1 . 27 ( 0 . 71 to 2 . 29 ) 1 . 02 ( 0 . 64 to 1 . 64 ) 1 . 39 ( 0 . 89 to 2 . 16 ) 1 . 08 ( 0 . 74 to 1 . 57 ) 106 % CVD ( 10 % increase ) 0 . 98 ( 0 . 67 to 1 . 45 ) 0 . 86 ( 0 . 57 to 1 . 31 ) 1 . 27 ( 0 . 90 to 1 . 77 ) 1 . 11 ( 0 . 80 to 1 . 52 ) 1 . 18 ( 0 . 90 to 1 . 54 ) 1 . 00 ( 0 . 77 to 1 . 30 ) 100 % Diabetes ( 10 % increase ) 1 . 18 ( 0 . 97 to 1 . 45 ) 1 . 10 ( 0 . 88 to 1 . 37 ) 1 . 33 ( 1 . 00 to 1 . 76 ) 1 . 00 ( 0 . 77 to 1 . 28 ) 1 . 24 ( 1 . 03 to 1 . 50 ) 1 . 03 ( 0 . 86 to 1 . 23 ) 126 % Corticosteroid ( 10 % increase ) 1 . 12 ( 0 . 91 to 1 . 39 ) 1 . 07 ( 0 . 88 to 1 . 29 ) 1 . 11 ( 0 . 95 to 1 . 30 ) 0 . 99 ( 0 . 87 to 1 . 12 ) 1 . 14 ( 0 . 99 to 1 . 30 ) 1 . 01 ( 0 . 91 to 1 . 14 ) 103 % IL - 6 inhibitor ( 10 % increase ) 1 . 27 ( 1 . 00 to 1 . 61 ) 1 . 06 ( 0 . 85 to 1 . 31 ) 1 . 05 ( 0 . 89 to 1 . 23 ) 0 . 98 ( 0 . 87 to 1 . 10 ) 1 . 12 ( 0 . 97 to 1 . 28 ) 0 . 99 ( 0 . 89 to 1 . 10 ) 65 Adjusted analysis accounts for median / mean study age , and severity index ( % of patients with severe COVID - 19 ) Setting and mechanical ventilation are only adjusted for ag J o u r n a l P r e - p r o o f 17 Figure 1 . PRISMA Study Flow Diagram J o u r n a l P r e - p r o o f 18 Figure 2 . Microbiological Characteristics of Bacterial Infection in Patients with COVID - 19 CNST = Coagulase Negative Staphylococcus spp . J o u r n a l P r e - p r o o f 19 Figure 3 . Forest Plot of Co - Infection and Secondary Infection Prevalence Based on Healthcare Setting Co - infection Secondary Infection J o u r n a l P r e - p r o o f 20 Figure 4 . Forest Plot of Co - Infection and Secondary Infection Prevalence Based on Specimen Source Co - infection Secondary Infection J o u r n a l P r e - p r o o f 21 J o u r n a l P r e - p r o o f 22 References 1 . Langford BJ , So M , Raybardhan S , Leung V , Westwood D , MacFadden DR , et al . Bacterial co - infection and secondary infection in patients with COVID - 19 : a living rapid review and meta - analysis . Clin Microbiol Infect [ Internet ] . 2020 Jul [ cited 2020 Jul 25 ] ; S1198743X20304237 . Available from : https : / / linkinghub . elsevier . com / retrieve / pii / S1198743X20304237 2 . Russell CD , Fairfield CJ , Drake TM , Turtle L , Seaton RA , Wootton DG , et al . Co - infections , secondary infections , and antimicrobial use in patients hospitalised with COVID - 19 during the first pandemic wave from the ISARIC WHO CCP - UK study : a multicentre , prospective cohort study . Lancet Microbe [ Internet ] . 2021 Jun [ cited 2021 Jun 30 ] ; S2666524721000902 . Available from : https : / / linkinghub . elsevier . com / retrieve / pii / S2666524721000902 3 . Vaughn VM , Gandhi TN , Petty LA , Patel PK , Prescott HC , Malani AN , et al . Empiric Antibacterial Therapy and Community - onset Bacterial Coinfection in Patients Hospitalized With Coronavirus Disease 2019 ( COVID - 19 ) : A Multi - hospital Cohort Study . Clin Infect Dis [ Internet ] . 2021 May 18 [ cited 2021 Jun 30 ] ; 72 ( 10 ) : e533 â 41 . Available from : https : / / academic . oup . com / cid / article / 72 / 10 / e533 / 5895253 4 . Langford BJ , So M , Raybardhan S , Leung V , Soucy J - PR , Westwood D , et al . Antibiotic prescribing in patients with COVID - 19 : rapid review and meta - analysis . Clin Microbiol Infect [ Internet ] . 2021 Apr [ cited 2021 Jun 30 ] ; 27 ( 4 ) : 520 â 31 . Available from : https : / / linkinghub . elsevier . com / retrieve / pii / S1198743X20307783 5 . Chong WH , Saha BK , Ananthakrishnan Ramani , Chopra A . State - of - the - art review of secondary pulmonary infections in patients with COVID - 19 pneumonia . Infection [ Internet ] . 2021 Mar 11 [ cited 2021 Jun 30 ] ; Available from : http : / / link . springer . com / 10 . 1007 / s15010 - 021 - 01602 - z 6 . Grasselli G , Scaravilli V , Mangioni D , Scudeller L , Alagna L , Bartoletti M , et al . Hospital - Acquired Infections in Critically Ill Patients With COVID - 19 . Chest [ Internet ] . 2021 Apr [ cited 2021 Jul 21 ] ; S0012369221006796 . Available from : https : / / linkinghub . elsevier . com / retrieve / pii / S0012369221006796 7 . Cochrane Rapid Reviews Interim Guidance from the Cochrane Rapid Reviews Methods Group . 8 . Langford BJ , So M , Raybardhan S , Leung V , Westwood D , MacFadden DR , et al . Bacterial co - infection and secondary infection in patients with COVID - 19 : a living rapid review and meta - analysis . Clin Microbiol Infect [ Internet ] . 2020 Jul [ cited 2020 Jul 25 ] ; S1198743X20304237 . Available from : https : / / linkinghub . elsevier . com / retrieve / pii / S1198743X20304237 9 . Viera AJ , Garrett JM . Understanding interobserver agreement : the kappa statistic . Fam Med . 2005 May ; 37 ( 5 ) : 360 â 3 . 10 . Hoy D , Brooks P , Woolf A , Blyth F , March L , Bain C , et al . Assessing risk of bias in prevalence studies : modification of an existing tool and evidence of interrater agreement . J Clin Epidemiol [ Internet ] . 2012 Sep [ cited 2020 May 5 ] ; 65 ( 9 ) : 934 â 9 . Available from : https : / / linkinghub . elsevier . com / retrieve / pii / S0895435612000790 11 . Lin L , Xu C . Arcsine - based transformations for meta - analysis of proportions : Pros , cons , and alternatives . Health Sci Rep . 2020 Sep ; 3 ( 3 ) : e178 . J o u r n a l P r e - p r o o f 23 12 . Lin L , Chu H . Meta - analysis of Proportions Using Generalized Linear Mixed Models . Epidemiology [ Internet ] . 2020 Sep [ cited 2020 Nov 7 ] ; 31 ( 5 ) : 713 â 7 . Available from : https : / / journals . lww . com / 10 . 1097 / EDE . 0000000000001232 13 . Deeks J , Higgins J , Altman D . Cochrane Handbook for Systematic Reviews of Interventions [ Internet ] . 2019 . Available from : https : / / training . cochrane . org / handbook 14 . Soucy J - P . Predictors and Microbiology of Co - Infection in Patients with COVID - 19 : Living Rapid Review Update and Meta - Regression Statistical Code [ Internet ] [ Internet ] . 2021 . Available from : https : / / github . com / jeanpaulrsoucy / covid - 19 - coinfection - metaregression 15 . OngrÃ¡di J , KÃ¶vesdi V . Factors that may impact on immunosenescence : an appraisal . Immun Ageing A . 2010 Jun 14 ; 7 : 7 . 16 . Levine SA , Niederman MS . The Impact of Tracheal Intubation on Host Defenses and Risks for Nosocomial Pneumonia . Clin Chest Med [ Internet ] . 1991 Sep [ cited 2021 Aug 24 ] ; 12 ( 3 ) : 523 â 43 . Available from : https : / / linkinghub . elsevier . com / retrieve / pii / S0272523121008005 17 . Alharthy A . , Aletreby W . , Faqihi F . , Balhamar A . , Alaklobi F . , Alanezi K . , et al . Clinical Characteristics and Predictors of 28 - Day Mortality in 352 Critically Ill Patients with COVID - 19 : A Retrospective Study . J Epidemiol Glob Health . 2020 ; ( ( Alharthy , Aletreby , Faqihi , Balhamar , Alanezi , Karakitsos ) Critical Care Department , King Saud Medical City , Riyadh , Saudi Arabia ( Alaklobi ) Pediatrics Department , King Saud Medical City , Riyadh , Saudi Arabia ( Jaganathan , Memish ) Research & Innovation Cent ) . 18 . Angelis V , Tippu Z , Joshi K , Reis S , Gronthoud F , Fribbens C , et al . Defining the true impact of coronavirus disease 2019 in the at - risk population of patients with cancer . Eur J Cancer Oxf Engl 1990 . 2020 ; 136 ( arv , 9005373 ) : 99 â 106 . 19 . Annane D . , Heming N . , Grimaldi - Bensouda L . , Fremeaux - Bacchi V . , Vigan M . , Roux A . - L . , et al . Eculizumab as an emergency treatment for adult patients with severe COVID - 19 in the intensive care unit : A proof - of - concept study . EClinicalMedicine [ Internet ] . 2020 ; 28 ( ( Annane ) FHU SEPSIS ( Saclay and Paris Seine Nord Endeavour to PerSonalize Interventions for Sepsis ) , RHU RECORDS ( Rapid rEcognition of CORticosteroiD resistant or sensitive Sepsis ) , Department of Intensive Care , Hopital Raymond Poincare ( APHP ) , Laboratory ) : 100590 . Available from : http : / / www . thelancet . com / journals / eclinm / issue / current 20 . Armann JP , Diffloth N , Simon A , Doenhardt M , Hufnagel M , Trotter A , et al . Hospital Admission in Children and Adolescents With COVID - 19 . Dtsch Arzteblatt Int . 2020 ; 117 ( 21 ) : 373 â 4 . 21 . Azoulay E , Fartoukh M , Darmon M , Geri G , Voiriot G , Dupont T , et al . Increased mortality in patients with severe SARS - CoV - 2 infection admitted within seven days of disease onset . Intensive Care Med . 2020 ; 46 ( 9 ) : 1714 â 22 . 22 . Bahl A . , Van Baalen M . N . , Ortiz L . , Chen N . - W . , Todd C . , Milad M . , et al . Early predictors of in - hospital mortality in patients with COVID - 19 in a large American cohort . Intern Emerg Med . 2020 ; 15 ( 8 ) : 1485 â 99 . J o u r n a l P r e - p r o o f 24 23 . Balena F . , Bavaro D . F . , Fabrizio C . , Bottalico I . F . , Calamo A . , Santoro C . R . , et al . Tocilizumab and corticosteroids for covid - 19 treatment in elderly patients . J Gerontol Geriatr [ Internet ] . 2020 ; 68 ( Special issue 4 ) : 197 â 203 . Available from : http : / / www . jgerontology - geriatrics . com / 24 . Balkhair A . , Al - Zakwani I . , Al Busaidi M . , Al - Khirbash A . , Al Mubaihsi S . , BaTaher H . , et al . Anakinra in hospitalized patients with severe COVID - 19 pneumonia requiring oxygen therapy : Results of a prospective , open - label , interventional study . Int J Infect Dis [ Internet ] . 2021 ; 103 ( ( Balkhair , BaTaher , Al Busaidi ) Department of Medicine , Infectious Diseases Unit , Sultan Qaboos University Hospital , PO Box 35 , Alkoudh 123 , Muscat , Oman ( Al - Zakwani , Al - Khirbash ) Department of Pharmacology & Clinical Pharmacy , College of Medicine & Health ) : 288 â 96 . Available from : https : / / www . journals . elsevier . com / international - journal - of - infectious - diseases 25 . Barbaro RP , MacLaren G , Boonstra PS , Iwashyna TJ , Slutsky AS , Fan E , et al . Extracorporeal membrane oxygenation support in COVID - 19 : an international cohort study of the Extracorporeal Life Support Organization registry . Lancet Lond Engl . 2020 ; 396 ( 10257 ) : 1071 â 8 . 26 . Bardi T . , Pintado V . , Gomez - Rojo M . , Escudero - Sanchez R . , Azzam Lopez A . , Diez - Remesal Y . , et al . Nosocomial infections associated to COVID - 19 in the intensive care unit : clinical characteristics and outcome . Eur J Clin Microbiol Infect Dis [ Internet ] . 2021 ; ( ( Bardi , Gomez - Rojo , Azzam Lopez , Diez - Remesal , Martinez Castro , Pestana ) Department of Anaesthesia and Intensive Care , Hospital Universitario Ramon y Cajal , Instituto Ramon y Cajal de Investigacion Sanitaria ( IRYCIS ) , M - 607 , km . 9 , 100 , Madrid 28034 , Spai ) . Available from : http : / / link . springer . de / link / service / journals / 10096 / index . htm 27 . Barry M . , AlMohaya A . , AlHijji A . , Akkielah L . , AlRajhi A . , Almajid F . , et al . Clinical characteristics and outcome of hospitalized COVID - 19 patients in a MERS - CoV endemic area . J Epidemiol Glob Health [ Internet ] . 2020 ; 10 ( 3 ) : 214 â 21 . Available from : https : / / www . atlantis - press . com / journals / jegh / 125941684 28 . Bartoletti M . , Marconi L . , Scudeller L . , Pancaldi L . , Tedeschi S . , Giannella M . , et al . Efficacy of corticosteroid treatment for hospitalized patients with severe COVID - 19 : a multicentre study . Clin Microbiol Infect [ Internet ] . 2021 ; 27 ( 1 ) : 105 â 11 . Available from : https : / / www . journals . elsevier . com / clinical - microbiology - and - infection 29 . Becchetti C , Zambelli MF , Pasulo L , Donato MF , Invernizzi F , Detry O , et al . COVID - 19 in an international European liver transplant recipient cohort . Gut . 2020 ; 69 ( 10 ) : 1832 â 40 . 30 . Bhatt P . J . , Shiau S . , Brunetti L . , Xie Y . , Solanki K . , Khalid S . , et al . Risk Factors and Outcomes of Hospitalized Patients with Severe COVID - 19 and Secondary Bloodstream Infections : A Multicenter , Case - Control Study . Clin Infect Dis Off Publ Infect Dis Soc Am . 2020 ; ( ( Bhatt , Solanki , Narayanan ) Department of Medicine , Division of Allergy / Immunology and Infectious Disease , Rutgers Robert Wood Johnson Medical School , NB ( Bhatt , Brunetti , Narayanan ) Department of Pharmacy Practice and Administration , Rutgers University Er ) . 31 . Bonazzetti C , Morena V , Giacomelli A , Oreni L , Casalini G , Galimberti LR , et al . Unexpectedly High Frequency of Enterococcal Bloodstream Infections in Coronavirus Disease 2019 Patients Admitted to an Italian ICU : An Observational Study . Crit Care Med . 2021 ; 49 ( 1 ) : e31 â 40 . J o u r n a l P r e - p r o o f 25 32 . Boren H . K . , Thaulow C . M . , Quist - Paulsen E . , Waehre T . , Akselsen P . E . , Tonby K . Tidsskr Den Nor Laegeforening Tidsskr Prakt Med Ny Raekke . 2020 ; 140 ( 11 ) . 33 . Borobia A . M . , Carcas A . J . , Arnalich F . , Alvarez - Sala R . , Monserrat - Villatoro J . , Quintana M . , et al . A cohort of patients with COVID - 19 in a major teaching hospital in Europe . J Clin Med [ Internet ] . 2020 ; 9 ( 6 ) : 1 â 10 . Available from : https : / / www . mdpi . com / 2077 - 0383 / 9 / 6 / 1733 / pdf 34 . Cai Q , Huang D , Ou P , Yu H , Zhu Z , Xia Z , et al . COVID - 19 in a designated infectious diseases hospital outside Hubei Province , China . Allergy . 2020 ; ( 39c , 7804028 ) . 35 . Campochiaro C . , Della - Torre E . , Cavalli G . , De Luca G . , Ripa M . , Boffini N . , et al . Efficacy and safety of tocilizumab in severe COVID - 19 patients : a single - centre retrospective cohort study . Eur J Intern Med [ Internet ] . 2020 ; ( ( Campochiaro , Della - Torre , Cavalli , De Luca , Ripa , Tomelleri , Rovere - Querini , De Cobelli , Zangrillo , Castagna , Dagna ) Vita - Salute San Raffaele University , Milan , Italy ( Campochiaro , Della - Torre , Cavalli , De Luca , Boffini , Tomelleri , Baldissera , Dagna ) Unit ) . Available from : http : / / www . elsevier . com / locate / ejim 36 . Cataldo M . A . , Tetaj N . , Selleri M . , Marchioni L . , Capone A . , Caraffa E . , et al . Incidence of bacterial and fungal bloodstream infections in COVID - 19 patients in intensive care : An alarming âcollateral effect . â J Glob Antimicrob Resist [ Internet ] . 2020 ; 23 ( ( Cataldo , Tetaj , Selleri , Marchioni , Capone , Caraffa , Caro , Petrosillo ) National Institute for Infectious Diseases Lazzaro Spallanzani - IRCCS , Rome , Italy ) : 290 â 1 . Available from : http : / / www . journals . elsevier . com / journal - of - global - antimicrobial - resistance / 37 . Cates J . , Lucero - Obusan C . , Dahl R . M . , Schirmer P . , Garg S . , Oda G . , et al . Risk for In - Hospital Complications Associated with COVID - 19 and Influenza - Veterans Health Administration , United States , October 1 , 2018 - May 31 , 2020 . MMWR Morb Mortal Wkly Rep . 2020 ; 69 ( 42 ) : 1528 â 34 . 38 . Cattelan A . M . , Di Meco E . , Trevenzoli M . , Frater A . , Ferrari A . , Villano M . , et al . Clinical characteristics and laboratory biomarkers changes in COVID - 19 patients requiring or not intensive or sub - intensive care : a comparative study . BMC Infect Dis [ Internet ] . 2020 ; 20 ( 1 ) : 934 . Available from : http : / / www . biomedcentral . com / bmcinfectdis / 39 . Chamorro - de - Vega E . , Rodriguez - Gonzalez C . - G . , Manrique - Rodriguez S . , Lobato - Matilla E . , Garcia - Moreno F . , Olmedo M . , et al . Clinical course of severe patients with COVID - 19 treated with tocilizumab : report from a cohort study in Spain . Expert Rev Clin Pharmacol [ Internet ] . 2021 ; ( ( Chamorro - de - Vega , Rodriguez - Gonzalez , Manrique - Rodriguez , Lobato - Matilla , Garcia - Moreno , Ruiz - Briones , Romero - Jimenez , Sarobe - Gonzalez , Gimenez - Manzorro , Collado - Borrell , Fernandez - Llamazares , Revuelta - Herrero , Somoza - Fernandez , Garcia - Sanchez , Taladriz - ) . Available from : https : / / www . tandfonline . com / loi / ierj20 40 . Chaudhary WA , Chong PL , Mani BI , Asli R , Momin RN , Abdullah MS , et al . Primary Respiratory Bacterial Coinfections in Patients with COVID - 19 . Am J Trop Med Hyg . 2020 ; ( 3zq , 0370507 ) . 41 . Chen L , Yu J , He W , Chen L , Yuan G , Dong F , et al . Risk factors for death in 1859 subjects with COVID - 19 . Leukemia . 2020 ; 34 ( 8 ) : 2173 â 83 . 42 . Chen N . , Zhou M . , Dong X . , Qu J . , Gong F . , Han Y . , et al . Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan , China : a descriptive J o u r n a l P r e - p r o o f 26 study . The Lancet [ Internet ] . 2020 ; 395 ( 10223 ) : 507 â 13 . Available from : http : / / www . journals . elsevier . com / the - lancet / 43 . Chen T , Dai Z , Mo P , Li X , Ma Z , Song S , et al . Clinical characteristics and outcomes of older patients with coronavirus disease 2019 ( COVID - 19 ) in Wuhan , China ( 2019 ) : a single - centered , retrospective study . J Gerontol A Biol Sci Med Sci . 2020 ; ( cba , 9502837 ) . 44 . Cheng K . , He M . , Shu Q . , Wu M . , Chen C . , Xue Y . Analysis of the risk factors for nosocomial bacterial infection in patients with COVID - 19 in a tertiary hospital . Risk Manag Healthc Policy [ Internet ] . 2020 ; 13 ( ( Cheng ) Department of Infection Management , Zhongda Hospital Affiliated to Southeast University , Nanjing 210009 , China ( He , Chen ) Department of Public Health , Huangshi Central Hospital , Huangshi 435000 , China ( Shu , Wu ) Department of Infection Prevention and ) : 2593 â 9 . Available from : https : / / www . dovepress . com / getfile . php ? fileID = 63728 45 . Cheng L . S . - K . , Chau S . K . - Y . , Tso E . Y . - K . , Tsang S . W . - C . , Li I . Y . - F . , Wong B . K . - C . , et al . Bacterial co - infections and antibiotic prescribing practice in adults with COVID - 19 : experience from a single hospital cluster . Ther Adv Infect Dis [ Internet ] . 2020 ; 7 ( ( Cheng ) Department of Pathology , United Christian Hospital , 130 Hip Wo Street , Kwun Tong , Kowloon , Hong Kong ( Chau , Wong , Fung ) Department of Pathology , United Christian Hospital , Hong Kong ( Tso ) Department of Medicine and Geriatrics , United Christian Hospi ) . Available from : http : / / tai . sagepub . com / 46 . Cobb N . L . , Sathe N . A . , Duan K . I . , Seitz K . P . , Thau M . R . , Sung C . C . , et al . Comparison of Clinical Features and Outcomes in Critically Ill Patients Hospitalized with COVID - 19 versus Influenza . Ann Am Thorac Soc . 2020 ; ( ( Cobb ) University of Washington , 7284 , Division of Pulmonary , Critical Care , and Sleep Medicine , Seattle , Washington , United States ; ( Sathe , Bhatraju ) University of Washington , Department of Internal Medicine , Division of Pulmonary , Critical Care and Sleep ) . 47 . Cobos - Siles M . , Cubero - Morais P . , Arroyo - Jimenez I . , Rey - Hernandez M . , Hernandez - Gomez L . , Vargas - Parra D . J . , et al . Cause - specific death in hospitalized individuals infected with SARS - CoV - 2 : more than just acute respiratory failure or thromboembolic events . Intern Emerg Med . 2020 ; 15 ( 8 ) : 1533 â 44 . 48 . Contou D . , Claudinon A . , Pajot O . , Micaelo M . , Longuet Flandre P . , Dubert M . , et al . Bacterial and viral co - infections in patients with severe SARS - CoV - 2 pneumonia admitted to a French ICU . Ann Intensive Care [ Internet ] . 2020 ; 10 ( 1 ) : 119 . Available from : http : / / www . annalsofintensivecare . com / 49 . Cordeanu E . - M . , Jambert L . , Severac F . , Lambach H . , Tousch J . , Heitz M . , et al . Outcomes of COVID - 19 hospitalized patients previously treated with renin - angiotensin system inhibitors . J Clin Med [ Internet ] . 2020 ; 9 ( 11 ) : 1 â 16 . Available from : https : / / www . mdpi . com / 2077 - 0383 / 9 / 11 / 3472 / pdf 50 . COVID - ICU Group on behalf of the REVA Network and the COVID - ICU Investigators . Clinical characteristics and day - 90 outcomes of 4244 critically ill adults with COVID - 19 : a prospective cohort study . Intensive Care Med . 2021 ; 47 ( 1 ) : 60 â 73 . 51 . DâOnofrio V . , Van Steenkiste E . , Meersman A . , Waumans L . , Cartuyvels R . , Van Halem K . , et al . Differentiating influenza from COVID - 19 in patients presenting with suspected sepsis . Eur J Clin Microbiol Infect Dis [ Internet ] . 2020 ; ( ( DâOnofrio , Messiaen , Gyssens ) Faculty of Medicine and Life J o u r n a l P r e - p r o o f 27 Sciences , Hasselt University , Hassel t , Belgium ( DâOnofrio , Van Steenkiste , Van Halem , Messiaen ) Department of Infectious Diseases and Immunity , Jessa Hospital , Hasselt , Belgium ( DâOnofrio , Gyssens ) ) . Available from : http : / / link . springer . de / link / service / journals / 10096 / index . htm 52 . Della - Torre E . , Campochiaro C . , Cavalli G . , De Luca G . , Napolitano A . , La Marca S . , et al . Interleukin - 6 blockade with sarilumab in severe COVID - 19 pneumonia with systemic hyperinflammation : An open - label cohort study . Ann Rheum Dis [ Internet ] . 2020 ; 79 ( 10 ) : 1277 â 85 . Available from : http : / / ard . bmj . com / 53 . Di Domenico S . L . , Coen D . , Bergamaschi M . , Albertini V . , Ghezzi L . , Cazzaniga M . M . , et al . Clinical characteristics and respiratory support of 310 COVID - 19 patients , diagnosed at the emergency room : a single - center retrospective study . Intern Emerg Med . 2020 ; ( ( Di Domenico ) Department of Emergency Medicine , ASST Grande Ospedale Metropolitano Niguarda , Piazza Ospedale Maggiore 3 , Milan 20162 , Italy ( Coen , Ghezzi , Cazzaniga , Tombini , Colombo , Cazzola , Di Fiore , Angaroni , Strozzi ) Department of Emergency Medicine , ) . 54 . Di Nisio M . , Potere N . , Candeloro M . , Spacone A . , Pieramati L . , Ferrandu G . , et al . Interleukin - 6 receptor blockade with subcutaneous tocilizumab improves coagulation activity in patients with COVID - 19 . Eur J Intern Med [ Internet ] . 2021 ; 83 ( ( Di Nisio , Candeloro ) Department of Medicine and Ageing Sciences , University G . DâAnnunzio , Chieti - Pescara , Italy ( Di Nisio ) Department of Vascular Medicine , Academic Medical Center , Amsterdam , Netherlands ( Potere , Pieramati , Rizzo , La Vella ) Department of ) : 34 â 8 . Available from : http : / / www . elsevier . com / locate / ejim 55 . Dreher M . , Kersten A . , Bickenbach J . , Balfanz P . , Hartmann B . , Cornelissen C . , et al . The characteristics of 50 hospitalized COVID - 19 patients with and without ARDS . Dtsch Arzteblatt Int [ Internet ] . 2020 ; 117 ( 16 ) : 271 â 8 . Available from : https : / / www . aerzteblatt . de / int / archive / issue ? heftid = 6485 56 . Dupuis C , Bouadma L , de Montmollin E , Goldgran - Toledano D , Schwebel C , Reignier J , et al . Association Between Early Invasive Mechanical Ventilation and Day - 60 Mortality in Acute Hypoxemic Respiratory Failure Related to Coronavirus Disease - 2019 Pneumonia . Crit Care Explor . 2021 ; 3 ( 1 ) : e0329 . 57 . Elabbadi A , Turpin M , Gerotziafas GT , Teulier M , Voiriot G , Fartoukh M . Bacterial coinfection in critically ill COVID - 19 patients with severe pneumonia . Infection . 2021 ; ( go8 , 0365307 ) . 58 . Elghoudi A , Aldhanhani H , Ghatasheh G , Sharif E , Narchi H . Covid - 19 in Children and Young Adolescents in Al Ain , United Arab Emirates - a Retrospective Cross - Sectional Study . Front Pediatr . 2020 ; 8 ( 101615492 ) : 603741 . 59 . Falcone M . , Tiseo G . , Giordano C . , Leonildi A . , Menichini M . , Vecchione A . , et al . Predictors of hospital - acquired bacterial and fungal superinfections in COVID - 19 : a prospective observational study . J Antimicrob Chemother . 2020 ; ( ( Falcone , Tiseo , Leonildi , Menichetti ) Infectious Disease Unit , Department of Clinical and Experimental Medicine , University of Pisa , Pisa , Italy ( Giordano , Menichini , Vecchione , Barnini ) Microbiology Unit , Azienda Ospedaliero Universitaria Pisana , Pisa , I ) . J o u r n a l P r e - p r o o f 28 60 . Feng G . , Huang W . - Q . , Liu M . - L . , Lin S . - C . , Zhang X . - Z . , Zhang Y . , et al . Clinical Features of COVID - 19 Patients in Xiaogan City . SN Compr Clin Med [ Internet ] . 2020 ; 2 ( 10 ) : 1717 â 23 . Available from : https : / / link . springer . com / journal / volumesAndIssues / 42399 61 . Feng Y , Ling Y , Bai T , Xie Y , Huang J , Li J , et al . COVID - 19 with Different Severity : A Multi - center Study of Clinical Features . Am J Respir Crit Care Med . 2020 ; ( 9421642 , bzs ) . 62 . Feng Z . , Yu Q . , Yao S . , Luo L . , Zhou W . , Mao X . , et al . Early prediction of disease progression in COVID - 19 pneumonia patients with chest CT and clinical characteristics . Nat Commun [ Internet ] . 2020 ; 11 ( 1 ) : 4968 . Available from : http : / / www . nature . com / ncomms / index . html 63 . Ferguson J , Rosser JI , Quintero O , Scott J , Subramanian A , Gumma M , et al . Characteristics and Outcomes of Coronavirus Disease Patients under Nonsurge Conditions , Northern California , USA , March - April 2020 . Emerg Infect Dis . 2020 ; 26 ( 8 ) . 64 . Ferrando C . , Mellado - Artigas R . , Gea A . , Arruti E . , Aldecoa C . , Bordell A . , et al . Patient characteristics , clinical course and factors associated to ICU mortality in critically ill patients infected with SARS - CoV - 2 in Spain : A prospective , cohort , multicentre study . Rev Esp Anestesiol Reanim . 2020 ; 67 ( 8 ) : 425 â 37 . 65 . Fisler G . , Izard S . M . , Shah S . , Lewis D . , Kainth M . K . , Hagmann S . H . F . , et al . Characteristics and risk factors associated with critical illness in pediatric COVID - 19 . Ann Intensive Care [ Internet ] . 2020 ; 10 ( 1 ) : 171 . Available from : http : / / www . annalsofintensivecare . com / 66 . Galvez - Romero J . L . , Palmeros - Rojas O . , Real - Ramirez F . A . , Sanchez - Romero S . , Tome - Maxil R . , Ramirez - Sandoval M . P . , et al . Cyclosporine A plus low - dose steroid treatment in COVID - 19 improves clinical outcomes in patients with moderate to severe disease : A pilot study . J Intern Med [ Internet ] . 2020 ; ( ( Galvez - Romero ) From the , Departamento de investigacion , Hospital Regional , ISSSTE , Puebla , Mexico ( Palmeros - Rojas ) Area de Matematicas , Departamento de Preparatoria Agricola , Universidad Autonoma Chapingo , Texcoco , Mexico ( Real - Ramirez , Sanchez - Romero , Tom ) . Available from : http : / / onlinelibrary . wiley . com / journal / 10 . 1111 / ( ISSN ) 1365 - 2796 67 . Garazzino S . , Montagnani C . , Dona D . , Meini A . , Felici E . , Vergine G . , et al . Multicentre Italian study of SARS - CoV - 2 infection in children and adolescents , preliminary data as at 10 April 2020 . Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull . 2020 ; 25 ( 18 ) . 68 . Garcia - Vidal C . , Sanjuan G . , Moreno - Garcia E . , Puerta - Alcalde P . , Garcia - Pouton N . , Chumbita M . , et al . Incidence of co - infections and superinfections in hospitalized patients with COVID - 19 : a retrospective cohort study . Clin Microbiol Infect [ Internet ] . 2021 ; 27 ( 1 ) : 83 â 8 . Available from : https : / / www . journals . elsevier . com / clinical - microbiology - and - infection 69 . Gavin W . , Campbell E . , Zaidi S . - A . , Gavin N . , Dbeibo L . , Beeler C . , et al . Clinical characteristics , outcomes and prognosticators in adult patients hospitalized with COVID - 19 . Am J Infect Control [ Internet ] . 2021 ; 49 ( 2 ) : 158 â 65 . Available from : http : / / www . journals . elsevier . com / ajic - american - journal - of - infection - control / 70 . Giacobbe DR , Battaglini D , Ball L , Brunetti I , Bruzzone B , Codda G , et al . Bloodstream infections in critically ill patients with COVID - 19 . Eur J Clin Invest . 2020 ; 50 ( 10 ) : e13319 . J o u r n a l P r e - p r o o f 29 71 . Goncalves Mendes Neto A . , Lo K . B . , Wattoo A . , Salacup G . , Pelayo J . , DeJoy R . , et al . Bacterial infections and patterns of antibiotic use in patients with COVID - 19 . J Med Virol [ Internet ] . 2021 ; 93 ( 3 ) : 1489 â 95 . Available from : http : / / onlinelibrary . wiley . com / journal / 10 . 1002 / ( ISSN ) 1096 - 9071 72 . Gottlieb M , Sansom S , Frankenberger C , Ward E , Hota B . Clinical Course and Factors Associated With Hospitalization and Critical Illness Among COVID - 19 Patients in Chicago , Illinois . Acad Emerg Med Off J Soc Acad Emerg Med . 2020 ; 27 ( 10 ) : 963 â 73 . 73 . Guaraldi G . , Meschiari M . , Cozzi - Lepri A . , Milic J . , Tonelli R . , Menozzi M . , et al . Tocilizumab in patients with severe COVID - 19 : a retrospective cohort study . Lancet Rheumatol [ Internet ] . 2020 ; 2 ( 8 ) : e474 â 84 . Available from : https : / / www . journals . elsevier . com / the - lancet - rheumatology 74 . Guo L . , Xiong W . , Liu D . , Feng Y . , Wang P . , Dong X . , et al . The mncp - spi score predicting risk of severe covid - 19 among mild - pneumonia patients on admission . Infect Drug Resist [ Internet ] . 2020 ; 13 ( ( Guo , Liu , Feng , Chen , Huang , Lu , Xie , Lin , Yan , Zhou , Qu ) Department of Respiratory and Critical Care Medicine , Ruijin Hospital , Shanghai Jiao Tong University School of Medicine , Shanghai , China ( Guo , Liu , Feng , Chen , Huang , Lu , Xie , Lin , Yan , Zhou , Qu ) I ) : 3593 â 600 . Available from : https : / / www . dovepress . com / getfile . php ? fileID = 62556 75 . He F . , Ding X . - F . , Cao M . , Gong H . - Y . , Fu X . - Z . , Luo J . , et al . Comparative Analysis of 95 Patients with Different Severity in the Early Outbreak of COVID - 19 in Wuhan , China . Can J Infect Dis Med Microbiol [ Internet ] . 2020 ; 2020 ( ( He , Gong , Chen , Jiang ) Department of Respiratory and Critical Care Medicine , Affiliated Hospital , North Sichuan Medical College , Nanchong , China ( He , Gong , Fu , Luo , Liu , Tian , Luo , Jiang ) North Sichuan Medical College , Nanchong , China ( He , Jiang ) Nanchong ) : 4783062 . Available from : http : / / www . hindawi . com / journals / cjidmm / 76 . Hughes S , Troise O , Donaldson H , Mughal N , Moore LSP . Bacterial and fungal coinfection among hospitalized patients with COVID - 19 : a retrospective cohort study in a UK secondary - care setting . Clin Microbiol Infect [ Internet ] . 2020 Oct [ cited 2020 Oct 15 ] ; 26 ( 10 ) : 1395 â 9 . Available from : https : / / linkinghub . elsevier . com / retrieve / pii / S1198743X20303694 77 . Ignatius EH , Wang K , Karaba A , Robinson M , Avery RK , Blair P , et al . Tocilizumab for the Treatment of COVID - 19 Among Hospitalized Patients : A Matched Retrospective Cohort Analysis . Open Forum Infect Dis . 2021 ; 8 ( 1 ) : ofaa598 . 78 . Ip A , Berry DA , Hansen E , Goy AH , Pecora AL , Sinclaire BA , et al . Hydroxychloroquine and tocilizumab therapy in COVID - 19 patients - An observational study . PloS One . 2020 ; 15 ( 8 ) : e0237693 . 79 . Jang J . G . , Hur J . , Choi E . Y . , Hong K . S . , Lee W . , Ahn J . H . Prognostic Factors for Severe Coronavirus Disease 2019 in Daegu , Korea . J Korean Med Sci . 2020 ; 35 ( 23 ) : e209 . 80 . Javanian M , Bayani M , Shokri M , Sadeghi - Haddad - Zavareh M , Babazadeh A , Yeganeh B , et al . Clinical and laboratory findings from patients with COVID - 19 pneumonia in Babol North of Iran : a retrospective cohort study . Romanian J Intern Med Rev Roum Med Interne . 2020 ; ( bos , 9304507 ) . J o u r n a l P r e - p r o o f 30 81 . Javanian M . , Bayani M . , Shokri M . , Sadeghi - Haddad - Zavareh M . , Babazadeh A . , Ghadimi R . , et al . Risk factors for mortality of 557 adult patients with COVID 19 in Babol , Northern Iran : a retrospective cohort study . Bratisl Lek Listy . 2021 ; 122 ( 1 ) : 34 â 8 . 82 . Jimenez E , Fontan - Vela M , Valencia J , Fernandez - Jimenez I , Alvaro - Alonso EA , Izquierdo - Garcia E , et al . Characteristics , complications and outcomes among 1549 patients hospitalised with COVID - 19 in a secondary hospital in Madrid , Spain : a retrospective case series study . BMJ Open . 2020 ; 10 ( 11 ) : e042398 . 83 . Karaba SM , Jones G , Helsel T , Smith LL , Avery R , Dzintars K , et al . Prevalence of Co - infection at the Time of Hospital Admission in COVID - 19 Patients , A Multicenter Study . Open Forum Infect Dis [ Internet ] . 2021 Jan 1 [ cited 2021 Aug 6 ] ; 8 ( 1 ) : ofaa578 . Available from : https : / / academic . oup . com / ofid / article / doi / 10 . 1093 / ofid / ofaa578 / 6042813 84 . Karami Z . , Knoop B . T . , Dofferhoff A . S . M . , Blaauw M . J . T . , Janssen N . A . , van Apeldoorn M . , et al . Few bacterial co - infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID - 19 : results from a multicentre retrospective cohort study in The Netherlands . Infect Dis [ Internet ] . 2021 ; 53 ( 2 ) : 102 â 10 . Available from : http : / / www . tandfonline . com / loi / infd20 # . VrgcOLdf1Fo 85 . Karmen - Tuohy S . , Carlucci P . M . , Zervou F . N . , Zacharioudakis I . M . , Rebick G . , Klein E . , et al . Outcomes Among HIV - Positive Patients Hospitalized With COVID - 19 . J Acquir Immune Defic Syndr 1999 . 2020 ; 85 ( 1 ) : 6 â 10 . 86 . Kewan T . , Covut F . , Al - Jaghbeer M . J . , Rose L . , Gopalakrishna K . V . , Akbik B . Tocilizumab for treatment of patients with severe COVID - 19 : A retrospective cohort study . EClinicalMedicine [ Internet ] . 2020 ; 24 ( ( Kewan , Covut ) Department of Internal Medicine , Cleveland Clinic Fairview Hospital , Cleveland , OH 44111 , United States ( Al - Jaghbeer , Akbik ) Department of Pulmonary and Critical Care Medicine , Cleveland Clinic , Cleveland , OH , United States ( Rose ) Department ) : 100418 . Available from : http : / / www . thelancet . com / journals / eclinm / issue / current 87 . Kimmig L . M . , Wu D . , Gold M . , Pettit N . N . , Pitrak D . , Mueller J . , et al . IL - 6 Inhibition in Critically Ill COVID - 19 Patients Is Associated With Increased Secondary Infections . Front Med [ Internet ] . 2020 ; 7 ( ( Kimmig , Wu , Gold , Pettit , Pitrak , Mutlu ) Department of Medicine , University of Chicago , Chicago , IL , United States ( Kimmig , Wu , Mutlu ) Section of Pulmonary and Critical Care Medicine , University of Chicago , Chicago , IL , United States ( Pettit , Pitrak ) Secti ) : 583897 . Available from : http : / / journal . frontiersin . org / journal / medicine 88 . Kolenda C . , Ranc A . - G . , Boisset S . , Caspar Y . , Carricajo A . , Souche A . , et al . Assessment of Respiratory Bacterial Coinfections among Severe Acute Respiratory Syndrome Coronavirus 2 - Positive Patients Hospitalized in Intensive Care Units Using Conventional Culture and BioFire , FilmArray Pneumonia Panel plus Assay . Open Forum Infect Dis [ Internet ] . 2020 ; 7 ( 11 ) : ofaa484 . Available from : https : / / academic . oup . com / ofid 89 . Kumar G . , Adams A . , Hererra M . , Rojas E . R . , Singh V . , Sakhuja A . , et al . Predictors and outcomes of healthcare - associated infections in COVID - 19 patients . Int J Infect Dis [ Internet ] . 2021 ; 104 ( ( Kumar , Rojas , Kethireddy ) Department of Pulmonary & Critical Care , Northeast Georgia Health System , Gainesville , GA , United States ( Adams , Hererra ) Department of Internal Medicine , J o u r n a l P r e - p r o o f 31 Northeast Georgia Health System , Gainesville , GA , United States ( Singh ) Dep ) : 287 â 92 . Available from : https : / / www . journals . elsevier . com / international - journal - of - infectious - diseases 90 . Lardaro T . , Wang A . Z . , Bucca A . , Croft A . , Glober N . , Holt D . B . , et al . Characteristics of COVID - 19 Patients with Bacterial Co - infection Admitted to the Hospital from the Emergency Department in a Large Regional Healthcare System . J Med Virol . 2021 ; ( ( Lardaro , Wang , Bucca , Croft , Glober , Holt , Musey , Peterson , Hunter ) Department of Emergency Medicine , Indiana University School of Medicine ( Holt , Trigonis ) Department of Pulmonary and Critical Care Medicine , Indiana University School of Medicine ) . 91 . Lee S - I , Koh JS , Kim YJ , Kang DH , Park D , Park HS , et al . Secondary infection among hospitalized COVID - 19 patients : A retrospective cohort study in a tertiary care setting . Respirol Carlton Vic . 2020 ; ( czg , 9616368 ) . 92 . Lehmann C . J . , Pho M . T . , Pitrak D . , Ridgway J . P . , Pettit N . N . Community Acquired Co - infection in COVID - 19 : A Retrospective Observational Experience . Clin Infect Dis Off Publ Infect Dis Soc Am . 2020 ; ( ( Lehmann , Pho , Pitrak , Ridgway ) Department of Medicine , Section of Infectious Disease and Global Health , University of Chicago Medicine , Chicago , Mexico ( Pettit ) Department of Pharmacy , University of Chicago Medicine , Chicago , Mexico ) . 93 . Lendorf M . E . , Boisen M . K . , Kristensen P . L . , Lokkegaard E . C . L . , Krog S . M . , Brandi L . , et al . Characteristics and early outcomes of patients hospitalised for covid - 19 in North Zealand , Denmark . Dan Med J [ Internet ] . 2020 ; 67 ( 9 ) : 1 â 11 . Available from : https : / / ugeskriftet . dk / files / scientific _ article _ files / 2020 - 08 / a06200428 _ web . pdf 94 . Li J , Li M , Zheng S , Li M , Zhang M , Sun M , et al . Plasma albumin levels predict risk for nonsurvivors in critically ill patients with COVID - 19 . Biomark Med . 2020 ; ( 101312535 ) . 95 . Li J . , Wang J . , Yang Y . , Cai P . , Cao J . , Cai X . , et al . Etiology and antimicrobial resistance of secondary bacterial infections in patients hospitalized with COVID - 19 in Wuhan , China : a retrospective analysis . Antimicrob Resist Infect Control [ Internet ] . 2020 ; 9 ( 1 ) : 153 . Available from : http : / / www . aricjournal . com / 96 . Li X , Xu S , Yu M , Wang K , Tao Y , Zhou Y , et al . Risk factors for severity and mortality in adult COVID - 19 inpatients in Wuhan . J Allergy Clin Immunol . 2020 ; ( h53 , 1275002 ) . 97 . Li Y . , Deng W . , Xiong H . , Li H . , Chen Z . , Nie Y . , et al . Immune - related factors associated with pneumonia in 127 children with coronavirus disease 2019 in Wuhan . Pediatr Pulmonol [ Internet ] . 2020 ; 55 ( 9 ) : 2354 â 60 . Available from : http : / / onlinelibrary . wiley . com / journal / 10 . 1002 / ( ISSN ) 1099 - 0496 98 . Lian J , Jin X , Hao S , Cai H , Zhang S , Zheng L , et al . Analysis of Epidemiological and Clinical features in older patients with Corona Virus Disease 2019 ( COVID - 19 ) out of Wuhan . Clin Infect Dis Off Publ Infect Dis Soc Am . 2020 ; ( a4j , 9203213 ) . 99 . Liu W . , Tao Z . - W . , Lei W . , Ming - Li Y . , Kui L . , Ling Z . , et al . Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease . Chin Med J ( Engl ) . 2020 ; ( ( Ming ) Central Hospital of Wuhan , Tongji Medical College , Huazhong University of Science and Technology , Wuhan , Hubei 430014 , China ) . J o u r n a l P r e - p r o o f 32 100 . Liu Z . , Li X . , Fan G . , Zhou F . , Huang L . , Yu J . , et al . Low - to - moderate dose corticosteroids treatment in hospitalized adults with COVID - 19 . Clin Microbiol Infect [ Internet ] . 2021 ; 27 ( 1 ) : 112 â 7 . Available from : https : / / www . journals . elsevier . com / clinical - microbiology - and - infection 101 . Llitjos J . - F . , Bredin S . , Lascarrou J . - B . , Soumagne T . , Cojocaru M . , Leclerc M . , et al . Increased susceptibility to intensive care unit - acquired pneumonia in severe COVID - 19 patients : a multicentre retrospective cohort study . Ann Intensive Care [ Internet ] . 2021 ; 11 ( 1 ) : 20 . Available from : http : / / www . annalsofintensivecare . com / 102 . Luduena MG , Labato M , Chiaradia V , Yamuni J , Finocchietto P , Pisarevsky AA . [ Analysis of the first 100 patients with COVID - 19 admitted to internal medicine wards at the Hospital de Clinicas Jose de San Martin , Buenos Aires University ] . Medicina ( Mex ) . 2020 ; 80 Suppl 6 ( mmm , 0204271 ) : 48 â 55 . 103 . Lui G . C . - Y . , Yip T . C . - F . , Wong V . W . - S . , Chow V . C . - Y . , Ho T . H . - Y . , Li T . C . - M . , et al . Significantly Lower Case - fatality Ratio of Coronavirus Disease 2019 ( COVID - 19 ) than Severe Acute Respiratory Syndrome ( SARS ) in Hong Kong - A Territory - Wide Cohort Study . Clin Infect Dis Off Publ Infect Dis Soc Am . 2020 ; ( ( Lui , Yip , Wong , Ho , Li , Tse , Chan , Hui , Wong ) Department of Medicine and Therapeutics , Chinese University of Hong Kong , Hong Kong SAR , China ( Lui , Yip , Wong , Tse , Chan , Hui , Wong ) Medical Data Analytic Centre ( MDAC ) , Chinese University of Hong Kong , Hong ) . 104 . Luyt C . - E . , Sahnoun T . , Gautier M . , Vidal P . , Burrel S . , Pineton de Chambrun M . , et al . Ventilator - associated pneumonia in patients with SARS - CoV - 2 - associated acute respiratory distress syndrome requiring ECMO : a retrospective cohort study . Ann Intensive Care [ Internet ] . 2020 ; 10 ( 1 ) : 158 . Available from : http : / / www . annalsofintensivecare . com / 105 . Lv Z , Cheng S , Le J , Huang J , Feng L , Zhang B , et al . Clinical characteristics and co - infections of 354 hospitalized patients with COVID - 19 in Wuhan , China : a retrospective cohort study . Microbes Infect . 2020 ; ( dj1 , 100883508 ) . 106 . Mady A . , Aletreby W . , Abdulrahman B . , Lhmdi M . , Noor A . M . , Alqahtani S . A . , et al . Tocilizumab in the treatment of rapidly evolving COVID - 19 pneumonia and multifaceted critical illness : A retrospective case series . Ann Med Surg [ Internet ] . 2020 ; 60 ( ( Mady , Aletreby , Abdulrahman , Lhmdi , Noor , Soliman , Alharthy , Karakitsos ) Critical Care Department , King Saud Medical City , Riyadh , Saudi Arabia ( Mady ) Department of Anesthesiology and Critical Care , Tanta University Hospitals , Tanta , Egypt ( Alqahtani ) Depa ) : 417 â 24 . Available from : http : / / www . elsevier . com / journals / annals - of - medicine - and - surgery / 2049 - 0801 107 . Maes M . , Higginson E . , Pereira - Dias J . , Curran M . D . , Parmar S . , Khokhar F . , et al . Ventilator - associated pneumonia in critically ill patients with COVID - 19 . Crit Care [ Internet ] . 2021 ; 25 ( 1 ) : 25 . Available from : http : / / ccforum . com / content / 17 108 . Mahmoudi H . Bacterial co - infections and antibiotic resistance in patients with COVID - 19 . GMS Hyg Infect Control . 2020 ; 15 ( 101609519 ) : Doc35 . 109 . McCracken J . A . , Nakeshbandi M . , Arace J . , Riley W . J . , Sharma R . COVID - 19 related deaths in an urban academic medical center in Brooklyn - A descriptive case series . Transl Med Commun [ Internet ] . 2020 ; 5 ( 1 ) : 12 . Available from : https : / / transmedcomms . biomedcentral . com / J o u r n a l P r e - p r o o f 33 110 . Mendizabal M . , Pinero F . , Ridruejo E . , Anders M . , Silveyra M . D . , Torre A . , et al . Prospective Latin American cohort evaluating outcomes of patients with COVID - 19 and abnormal liver tests on admission . Ann Hepatol [ Internet ] . 2021 ; 21 ( ( Mendizabal , Pinero , Pages , Silva ) Hepatology and Liver Transplant Unit , Hospital Universitario Austral , Pilar , Argentina ( Mendizabal , Pinero , Ridruejo , Anders , Pages , Peralta , Varon , Schinoni , Silva ) Latin American Liver Research Educational and Awareness ) : 100298 . Available from : https : / / www . journals . elsevier . com / annals - of - hepatology 111 . Mo P , Xing Y , Xiao Y , Deng L , Zhao Q , Wang H , et al . Clinical characteristics of refractory COVID - 19 pneumonia in Wuhan , China . Clin Infect Dis Off Publ Infect Dis Soc Am . 2020 ; ( a4j , 9203213 ) . 112 . Morena V , Milazzo L , Oreni L , Bestetti G , Fossali T , Bassoli C , et al . Off - label use of tocilizumab for the treatment of SARS - CoV - 2 pneumonia in Milan , Italy . Eur J Intern Med . 2020 ; 76 ( 9003220 ) : 36 â 42 . 113 . Moreno - Perez O . , Andres M . , Leon - Ramirez J . - M . , Sanchez - Paya J . , Rodriguez J . C . , Sanchez R . , et al . Experience with tocilizumab in severe COVID - 19 pneumonia after 80 days of follow - up : A retrospective cohort study . J Autoimmun [ Internet ] . 2020 ; 114 ( ( Moreno - Perez ) Endocrinology and Nutrition Department , Alicante General University Hospital - Alicante Institute of Sanitary and Biomedical Research ( ISABIAL ) , Alicante , Spain ( Moreno - Perez , Andres , Boix ) Clinical Medicine Department , Miguel Hernandez Univ ) : 102523 . Available from : http : / / www . elsevier . com / inca / publications / store / 6 / 2 / 2 / 8 / 5 / 6 / index . htt 114 . Morrison A . R . , Johnson J . M . , Griebe K . M . , Jones M . C . , Stine J . J . , Hencken L . N . , et al . Clinical characteristics and predictors of survival in adults with coronavirus disease 2019 receiving tocilizumab . J Autoimmun [ Internet ] . 2020 ; 114 ( ( Morrison , Johnson , Griebe , Jones , Stine , Hencken , To , Peters , Smith ) Department of Pharmacy , Henry Ford Hospital , 2799 West Grand Blvd , Detroit , MI 48202 , United States ( Bianchini ) Department of Clinical Pharmacy , University of Colorado Anschutz Medical C ) : 102512 . Available from : http : / / www . elsevier . com / inca / publications / store / 6 / 2 / 2 / 8 / 5 / 6 / index . htt 115 . Munoz P . , Galar A . , Catalan P . , Valerio M . , Aldamiz - Echevarria T . , Colliga C . , et al . The first 100 cases of covid - 19 in a hospital in madrid with a 2 - month follow - up . Rev Esp Quimioter [ Internet ] . 2020 ; 33 ( 5 ) : 369 â 78 . Available from : https : / / seq . es / wp - content / uploads / 2020 / 07 / munoz30jul2020 . pdf 116 . Nebreda - Mayoral T . , Miguel - Gomez M . A . , March - Rossello G . A . , Puente - Fuertes L . , Canton - Benito E . , Martinez - Garcia A . M . , et al . Bacterial / fungal infection in hospitalized patients with COVID - 19 in a tertiary hospital in the Community of Castilla y Leon , Spain . Enferm Infecc Microbiol Clin [ Internet ] . 2021 ; ( ( Nebreda - Mayoral , Miguel - Gomez , March - Rossello , Puente - Fuertes , Canton - Benito , Martinez - Garcia , Orduna - Domingo ) Servicio de Microbiologia e Inmunologia , Hospital Clinico Universitario de Valladolid , Valladolid , Spain ( Munoz - Martin ) Servicio de Farmacia , Ho ) . Available from : https : / / www . sciencedirect . com / journal / enfermedades - infecciosas - y - microbiologia - clinica / issues 117 . Nicolas D , Camos - Carreras A , Spencer F , Arenas A , Butori E , Maymo P , et al . A Prospective Cohort of SARS - CoV - 2 - Infected Health Care Workers : Clinical Characteristics , Outcomes , and Follow - up Strategy . Open Forum Infect Dis . 2021 ; 8 ( 1 ) : ofaa592 . J o u r n a l P r e - p r o o f 34 118 . Nori P . , Cowman K . , Chen V . , Bartash R . , Szymczak W . , Madaline T . , et al . Bacterial and fungal coinfections in COVID - 19 patients hospitalized during the New York City pandemic surge . Infect Control Hosp Epidemiol [ Internet ] . 2021 ; 42 ( 1 ) : 84 â 8 . Available from : http : / / www . journals . uchicago . edu / ICHE / home . html 119 . Obata R . , Maeda T . , DO D . R . , Kuno T . Increased secondary infection in COVID - 19 patients treated with steroids in New York City . Jpn J Infect Dis . 2020 ; ( ( Obata , Maeda , DO , Kuno ) Department of Medicine , Icahn School of Medicine at Mount Sinai , Mount Sinai Beth Israel , United States ) . 120 . Odille G , Girard N , Sanchez S , Lelarge S , Mignot A , Putot S , et al . Should We Prescribe Antibiotics in Older Patients Presenting COVID - 19 Pneumonia ? . J Am Med Dir Assoc . 2020 ; ( 100893243 ) . 121 . Papamanoli A . , Yoo J . , Grewal P . , Predun W . , Hotelling J . , Jacob R . , et al . High - dose methylprednisolone in nonintubated patients with severe COVID - 19 pneumonia . Eur J Clin Invest [ Internet ] . 2021 ; 51 ( 2 ) : e13458 . Available from : http : / / onlinelibrary . wiley . com / journal / 10 . 1111 / ( ISSN ) 1365 - 2362 122 . Pereira A . , Cruz - Melguizo S . , Adrien M . , Fuentes L . , Marin E . , Perez - Medina T . Clinical course of coronavirus disease - 2019 in pregnancy . Acta Obstet Gynecol Scand [ Internet ] . 2020 ; 99 ( 7 ) : 839 â 47 . Available from : http : / / obgyn . onlinelibrary . wiley . com / hub / journal / 10 . 1111 / ( ISSN ) 1600 - 0412 / 123 . Pereira M . R . , Aversa M . M . , Farr M . A . , Miko B . A . , Aaron J . G . , Mohan S . , et al . Tocilizumab for severe COVID - 19 in solid organ transplant recipients : a matched cohort study . Am J Transplant [ Internet ] . 2020 ; 20 ( 11 ) : 3198 â 205 . Available from : http : / / onlinelibrary . wiley . com / journal / 10 . 1111 / ( ISSN ) 1600 - 6143 124 . Pettit N . N . , Nguyen C . T . , Mutlu G . M . , Wu D . , Kimmig L . , Pitrak D . , et al . Late onset infectious complications and safety of tocilizumab in the management of COVID - 19 . J Med Virol [ Internet ] . 2021 ; 93 ( 3 ) : 1459 â 64 . Available from : http : / / onlinelibrary . wiley . com / journal / 10 . 1002 / ( ISSN ) 1096 - 9071 125 . Piroth L . , Cottenet J . , Mariet A . - S . , Bonniaud P . , Blot M . , Tubert - Bitter P . , et al . Comparison of the characteristics , morbidity , and mortality of COVID - 19 and seasonal influenza : a nationwide , population - based retrospective cohort study . Lancet Respir Med [ Internet ] . 2021 ; ( ( Piroth , Mariet , Quantin ) Inserm CIC 1432 , Clinical Epidemiology / Clinical Trials Unit , Clinical Investigation Centre , Dijon University Hospital , Dijon , France ( Piroth , Blot ) Infectious Diseases Department , Dijon University Hospital , Dijon , France ( Cottenet , ) . Available from : http : / / www . elsevier . com / journals / the - lancet - respiratory - medicine / 2213 - 2600 126 . Pongpirul W . A . , Wiboonchutikul S . , Charoenpong L . , Panitantum N . , Vachiraphan A . , Uttayamakul S . , et al . Clinical course and potential predictive factors for pneumonia of adult patients with coronavirus disease 2019 ( COVID - 19 ) : A retrospective observational analysis of 193 confirmed cases in Thailand . PLoS Negl Trop Dis [ Internet ] . 2020 ; 14 ( 10 ) : 1 â 17 . Available from : https : / / journals . plos . org / plosntds / article / file ? id = 10 . 1371 / journal . pntd . 0008806 & type = printable 127 . Price C . C . , Altice F . L . , Shyr Y . , Koff A . , Pischel L . , Goshua G . , et al . Tocilizumab Treatment for Cytokine Release Syndrome in Hospitalized Patients With Coronavirus Disease 2019 : Survival and Clinical Outcomes . Chest [ Internet ] . 2020 ; 158 ( 4 ) : 1397 â 408 . Available from : http : / / www . chestjournal . org / J o u r n a l P r e - p r o o f 35 128 . Quartuccio L , Sonaglia A , Pecori D , Peghin M , Fabris M , Tascini C , et al . Higher levels of IL - 6 early after tocilizumab distinguish survivors from non - survivors in COVID - 19 pneumonia : a possible indication for deeper targeting IL - 6 . J Med Virol . 2020 ; ( i9n , 7705876 ) . 129 . Rahmani H . , Davoudi - Monfared E . , Nourian A . , Khalili H . , Hajizadeh N . , Jalalabadi N . Z . , et al . Interferon beta - 1b in treatment of severe COVID - 19 : A randomized clinical trial . Int Immunopharmacol [ Internet ] . 2020 ; 88 ( ( Rahmani , Davoudi - Monfared , Nourian , Khalili ) Department of Pharmacotherapy , Imam Khomeini Hospital Complex , Tehran University of Medical Sciences , Tehran , Iran , Islamic Republic of ( Hajizadeh ) Department of Infectious Diseases , Shohadaye Gomnam Hospital , ) : 106903 . Available from : http : / / www . elsevier . com / locate / intimp 130 . Ramadan H . K . - A . , Mahmoud M . A . , Zakaria M . , Aburahma , Elkhawaga A . A . , El - Mokhtar M . A . , et al . Predictors of severity and co - infection resistance profile in COVID - 19 patients : First report from upper Egypt . Infect Drug Resist [ Internet ] . 2020 ; 13 ( ( Ramadan , Aburahma , Hassany , Medhat ) Department of Tropical Medicine and Gastroenterology , Faculty of Medicine , Assiut University , Assiut , Egypt ( Mahmoud ) Department of Chest Diseases and Tuberculosis , Faculty of Medicine , Assiut University , Assiut , Egypt ( ) : 3409 â 22 . Available from : https : / / www . dovepress . com / getfile . php ? fileID = 62113 131 . Razazi K . , Arrestier R . , Haudebourg A . F . , Benelli B . , Carteaux G . , Decousser J . - W . , et al . Risks of ventilator - associated pneumonia and invasive pulmonary aspergillosis in patients with viral acute respiratory distress syndrome related or not to Coronavirus 19 disease . Crit Care [ Internet ] . 2020 ; 24 ( 1 ) : 699 . Available from : http : / / ccforum . com / content / 17 132 . Rinaldi M . , Bartoletti M . , Bussini L . , Pancaldi L . , Pascale R . , Comai G . , et al . COVID - 19 in solid organ transplant recipients : No difference in survival compared to general population . Transpl Infect Dis [ Internet ] . 2020 ; ( ( Rinaldi , Bartoletti , Bussini , Pancaldi , Pascale , Viale , Giannella ) Infectious Diseases Unit , Department of Medical and Surgical Sciences , Pol iclinico SantâOrsola Malpighi , University of Bologna , Bologna , Italy ( Comai ) Department of Experimental , Diagnosti ) . Available from : http : / / onlinelibrary . wiley . com / journal / 10 . 1111 / ( ISSN ) 1399 - 3062 133 . Ripa M . , Galli L . , Poli A . , Oltolini C . , Spagnuolo V . , Mastrangelo A . , et al . Secondary infections in patients hospitalized with COVID - 19 : incidence and predictive factors . Clin Microbiol Infect [ Internet ] . 2020 ; ( ( Ripa , Galli , Poli , Oltolini , Spagnuolo , Lazzarin , Scarpellini , Castagna ) Unit of Infectious and Tropical Diseases , IRCCS San Raffaele Scientific Institute , Milan , Italy ( Ripa , Spagnuolo , Mastrangelo , Muccini , Landoni , Dagna , Clementi , Rovere Querini , Cice ) . Available from : https : / / www . journals . elsevier . com / clinical - microbiology - and - infection 134 . Rodriguez - Garcia J . L . , Sanchez - Nievas G . , Arevalo - Serrano J . , Garcia - Gomez C . , Jimenez - Vizuete J . M . , Martinez - Alfaro E . Baricitinib improves respiratory function in patients treated with corticosteroids for SARS - CoV - 2 pneumonia : an observational cohort study . Rheumatol Oxf Engl . 2021 ; 60 ( 1 ) : 399 â 407 . 135 . Rojas - Marte G . , Khalid M . , Mukhtar O . , Hashmi A . T . , Waheed M . A . , Ehrlich S . , et al . Outcomes in patients with severe COVID - 19 disease treated with tocilizumab : A case - controlled study . QJM [ Internet ] . 2020 ; 113 ( 8 ) : 546 â 50 . Available from : http : / / qjmed . oxfordjournals . org / 136 . Rossotti R . , Travi G . , Ughi N . , Corradin M . , Baiguera C . , Fumagalli R . , et al . Safety and efficacy of anti - il6 - receptor tocilizumab use in severe and critical patients affected by coronavirus disease J o u r n a l P r e - p r o o f 36 2019 : A comparative analysis . J Infect [ Internet ] . 2020 ; 81 ( 4 ) : e11 â 7 . Available from : http : / / www . elsevier . com / inca / publications / store / 6 / 2 / 3 / 0 / 5 / 4 / index . htt 137 . Rothe K . , Feihl S . , Schneider J . , Wallnofer F . , Wurst M . , Lukas M . , et al . Rates of bacterial co - infections and antimicrobial use in COVID - 19 patients : a retrospective cohort study in light of antibiotic stewardship . Eur J Clin Microbiol Infect Dis [ Internet ] . 2020 ; ( ( Rothe , Feihl , Busch ) Institute for Medical Microbiology , Immunology and Hygiene , Technical University of Munich , School of Medicine , Trogerstr . 30 , Munich 81675 , Germany ( Schneider , Wallnofer , Wurst , Lukas , Treiber , Lahmer , Schmid , Spinner ) Department of ) . Available from : http : / / link . springer . de / link / service / journals / 10096 / index . htm 138 . Rouze A . , Martin - Loeches I . , Povoa P . , Makris D . , Artigas A . , Bouchereau M . , et al . Relationship between SARS - CoV - 2 infection and the incidence of ventilator - associated lower respiratory tract infections : a European multicenter cohort study . Intensive Care Med [ Internet ] . 2021 ; ( ( Rouze , Bouchereau , Nseir , Contou , Voiriot , Argaud , Nieszkowska ) CHU de Lille , Medecine Intensive - Reanimation , Lille 59000 , France ( Rouze , Nseir ) Universite de Lille , INSERM U995 , Team Fungal Associated Invasive and Inflammatory Diseases , Lille Inflammatio ) . Available from : http : / / link . springer . de / link / service / journals / 00134 / index . htm 139 . Salama C . , Han J . , Yau L . , Reiss W . G . , Kramer B . , Neidhart J . D . , et al . Tocilizumab in patients hospitalized with Covid - 19 pneumonia . N Engl J Med [ Internet ] . 2021 ; 384 ( 1 ) : 20 â 30 . Available from : http : / / www . nejm . org / medical - index 140 . Schmidt M , Hajage D , Lebreton G , Monsel A , Voiriot G , Levy D , et al . Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID - 19 : a retrospective cohort study . Lancet Respir Med . 2020 ; 8 ( 11 ) : 1121 â 31 . 141 . Schmidt M . , Hajage D . , Demoule A . , Pham T . , Combes A . , Dres M . , et al . Clinical characteristics and day - 90 outcomes of 4244 critically ill adults with COVID - 19 : a prospective cohort study . Intensive Care Med [ Internet ] . 2021 ; 47 ( 1 ) : 60 â 73 . Available from : http : / / link . springer . de / link / service / journals / 00134 / index . htm 142 . Sepulveda J , Westblade LF , Whittier S , Satlin MJ , Greendyke WG , Aaron JG , et al . Bacteremia and Blood Culture Utilization During COVID - 19 Surge in New York City . J Clin Microbiol . 2020 ; ( hsh , 7505564 ) . 143 . Shang Y . , Liu T . , Wei Y . , Li J . , Shao L . , Liu M . , et al . Scoring systems for predicting mortality for severe patients with COVID - 19 . EClinicalMedicine [ Internet ] . 2020 ; 24 ( ( Shang , Shao , Liu , Zhou ) Department of Hematology , Zhongnan Hospital of Wuhan University , 169 Donghu Road , Wuhan 430071 , China ( Liu , Wang ) Department of Urology , Zhongnan Hospital of Wuhan University , 169 Donghu Road , Wuhan 430071 , China ( Wei , Xu ) Departmen ) : 100426 . Available from : http : / / www . thelancet . com / journals / eclinm / issue / current 144 . Sharov K . S . SARS - CoV - 2 - related pneumonia cases in pneumonia picture in Russia in March - May 2020 : Secondary bacterial pneumonia and viral co - infections . J Glob Health . 2020 ; 10 ( 2 ) : 020504 . 145 . Shi P . , Ren G . , Yang J . , Li Z . , Deng S . , Li M . , et al . Clinical characteristics of imported and second - generation coronavirus disease 2019 ( COVID - 19 ) cases in Shaanxi outside Wuhan , China : A multicentre retrospective study . Epidemiol Infect [ Internet ] . 2020 ; ( ( Shi , Chen ) Department of J o u r n a l P r e - p r o o f 37 Respiratory and Critical Care Medicine , First Affiliated Hospital , Xiâan Jiaotong University , Xiâan , Shaanxi , China ( Ren ) Xiâan Chest Hospital , Xiâan , Shaanxi , China ( Yang , Xie ) Ankang City Central Hospital , Shaanxi , Ankang , China ( ) . Available from : http : / / journals . cambridge . org / action / displayJournal ? jid = HYG 146 . Sim BLH , Chidambaram SK , Wong XC , Pathmanathan MD , Peariasamy KM , Hor CP , et al . Clinical characteristics and risk factors for severe COVID - 19 infections in Malaysia : A nationwide observational study . Lancet Reg Health West Pac . 2020 ; 4 : 100055 . 147 . Sinha P . , Mostaghim A . , Bielick C . G . , McLaughlin A . , Hamer D . H . , Wetzler L . M . , et al . Early administration of interleukin - 6 inhibitors for patients with severe COVID - 19 disease is associated with decreased intubation , reduced mortality , and increased discharge . Int J Infect Dis [ Internet ] . 2020 ; 99 ( ( Sinha , McLaughlin , Hamer , Wetzler , Bhadelia , Fagan , Linas , Assoumou , Lin , Barlam , Sagar ) Section of Infectious Diseases , Department of Medicine , Boston University School of Medicine , Boston , MA , United States ( Mostaghim , Bielick ) Department of Medicine , B ) : 28 â 33 . Available from : https : / / www . journals . elsevier . com / international - journal - of - infectious - diseases 148 . Sogaard K . K . , Baettig V . , Osthoff M . , Marsch S . , Leuzinger K . , Schweitzer M . , et al . Community - acquired and hospital - acquired respiratory tract infection and bloodstream infection in patients hospitalized with COVID - 19 pneumonia . J Intensive Care [ Internet ] . 2021 ; 9 ( 1 ) : 10 . Available from : http : / / www . jintensivecare . com / 149 . Somers E . C . , Eschenauer G . A . , Troost J . P . , Golob J . L . , Gandhi T . N . , Wang L . , et al . Tocilizumab for treatment of mechanically ventilated patients with COVID - 19 . Clin Infect Dis Off Publ Infect Dis Soc Am . 2020 ; ( ( Somers , Golob , Gandhi , Petty , Baang , Gregg , Kaul , Zhou , Lauring , Sharma ) University of Michigan , Department of Internal Medicine , Ann Arbor , United States ( Somers ) University of Michigan , Department of Environmental Health Sciences , Ann Arbor , United Stat ) . 150 . Soriano MC , Vaquero C , Ortiz - Fernandez A , Caballero A , Blandino - Ortiz A , de Pablo R . Low incidence of co - infection , but high incidence of ICU - acquired infections in critically ill patients with COVID - 19 . J Infect . 2020 ; ( ig9 , 7908424 ) . 151 . Stevens RW , Je nsen K , OâHoro JC , Shah A . Antimicrobial prescribing practices at a tertiary - care center in patients diagnosed with COVID - 19 across the continuum of care . Infect Control Hosp Epidemiol . 2021 ; 42 ( 1 ) : 89 â 92 . 152 . Tomazini B . M . , Maia I . S . , Cavalcanti A . B . , Berwanger O . , Rosa R . G . , Veiga V . C . , et al . Effect of Dexamethasone on Days Alive and Ventilator - Free in Patients with Moderate or Severe Acute Respiratory Distress Syndrome and COVID - 19 : The CoDEX Randomized Clinical Trial . JAMA - J Am Med Assoc [ Internet ] . 2020 ; 324 ( 13 ) : 1307 â 16 . Available from : http : / / jama . jamanetwork . com / journal . aspx 153 . Townsend L . , Hughes G . , Kerr C . , Kelly M . , OâConnor R . , Sweeney E . , et al . Bacterial pneumonia coinfection and antimicrobial therapy duration in SARS - CoV - 2 ( COVID - 19 ) infection . JAC - Antimicrob Resist [ Internet ] . 2020 ; 2 ( 3 ) : dlaa071 . Available from : https : / / academic . oup . com / jacamr 154 . Tran V . - T . , Mahevas M . , Bani - Sadr F . , Robineau O . , Perpoint T . , Perrodeau E . , et al . Corticosteroids in patients hospitalized for COVID - 19 pneumonia who require oxygen : J o u r n a l P r e - p r o o f 38 observational comparative study using routine care data . Clin Microbiol Infect [ Internet ] . 2020 ; ( ( Tran , Perrodeau , Ravaud ) Centre dâEpidemiologie Clinique , Hopital Hotel - Dieu , Assistance Publique - Hopitaux de Paris , Paris 75004 , France ( Tran , Perrodeau , Ravaud ) Universite de Paris , CRESS , INSERM , INRA , Paris F - 75004 , France ( Mahevas ) Service de Medecine ) . Available from : https : / / www . journals . elsevier . com / clinical - microbiology - and - infection 155 . Vanhomwegen C , Veliziotis I , Malinverni S , Konopnicki D , Dechamps P , Claus M , et al . Procalcitonin accurately predicts mortality but not bacterial infection in COVID - 19 patients admitted to intensive care unit . Ir J Med Sci . 2021 ; ( gxb , 7806864 , 7806865 ) . 156 . Vena A , Giacobbe DR , Di Biagio A , Mikulska M , Taramasso L , De Maria A , et al . Clinical characteristics , management and in - hospital mortality of patients with coronavirus disease 2019 in Genoa , Italy . Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis . 2020 ; 26 ( 11 ) : 1537 â 44 . 157 . Wang A , Gao G , Wang S , Chen M , Qian F , Tang W , et al . Clinical Characteristics and Risk Factors of Acute Respiratory Distress Syndrome ( ARDS ) in COVID - 19 Patients in Beijing , China : A Retrospective Study . Med Sci Monit Int Med J Exp Clin Res . 2020 ; 26 ( dxw , 9609063 ) : e925974 . 158 . Wang J - B , Wang H - T , Wang L - S , Li L - P , Xv J , Xv C , et al . Epidemiological and clinical characteristics of fifty - six cases of COVID - 19 in Liaoning Province , China . World J Clin Cases . 2020 ; 8 ( 21 ) : 5188 â 202 . 159 . Wang K . , Qiu Z . , Liu J . , Fan T . , Liu C . , Tian P . , et al . Analysis of the clinical characteristics of 77 COVID - 19 deaths . Sci Rep . 2020 ; 10 ( 1 ) : 16384 . 160 . Wang Z , Ma W , Zheng X , Wu G , Zhang R . Household transmission of SARS - CoV - 2 . J Infect . 2020 ; ( ig9 , 7908424 ) . 161 . Wang L , Amin AK , Khanna P , Aali A , McGregor A , Bassett P , et al . An observational cohort study of bacterial co - infection and implications for empirical antibiotic therapy in patients presenting with COVID - 19 to hospitals in North West London . J Antimicrob Chemother [ Internet ] . 2021 Feb 11 [ cited 2021 Aug 6 ] ; 76 ( 3 ) : 796 â 803 . Available from : https : / / academic . oup . com / jac / article / 76 / 3 / 796 / 5980416 162 . Wang S , Chen Z , Lin Y , Lin L , Lin Q , Fang S , et al . Clinical characteristics of 199 discharged patients with COVID - 19 in Fujian Province : A multicenter retrospective study between January 22nd and February 27th , 2020 . PloS One . 2020 ; 15 ( 11 ) : e0242307 . 163 . Wu B . , Lei Z . - Y . , Wu K . - L . , He J . - R . , Cao H . - J . , Fu J . , et al . Compare the epidemiological and clinical features of imported and local COVID - 19 cases in Hainan , China . Infect Dis Poverty [ Internet ] . 2020 ; 9 ( 1 ) : 143 . Available from : http : / / www . idpjournal . com / 164 . Wu C . , Chen X . , Cai Y . , Xia J . , Xu S . , Huang H . , et al . Risk Factors Associated with Acute Respiratory Distress Syndrome and Death in Patients with Coronavirus Disease 2019 Pneumonia in Wuhan , China . JAMA Intern Med [ Internet ] . 2020 ; ( ( Song ) National Clinical Research Center for Aging and Medicine , Huashan Hospital , Fudan University , Shanghai , China ) . Available from : http : / / archinte . jamanetwork . com / issues . aspx J o u r n a l P r e - p r o o f 39 165 . Wu J , Li W , Shi X , Chen Z , Jiang B , Liu J , et al . Early antiviral treatment contributes to alleviate the severity and improve the prognosis of patients with novel coronavirus disease ( COVID - 19 ) . J Intern Med . 2020 ; ( i2g , 8904841 ) . 166 . Wu J , Huang Y , Tu C , Bi C , Chen Z , Luo L , et al . Household Transmission of SARS - CoV - 2 , Zhuhai , China , 2020 . Clin Infect Dis Off Publ Infect Dis Soc Am . 2020 ; ( a4j , 9203213 ) . 167 . Xiao L . - S . , Zhang W . - F . , Gong M . - C . , Zhang Y . - P . , Chen L . - Y . , Zhu H . - B . , et al . Development and validation of the HNC - LL score for predicting the severity of coronavirus disease 2019 . EBioMedicine [ Internet ] . 2020 ; 57 ( ( Xiao , Chen , Kang , Liu ) Department of Medical Quality Management , Nanfang Hospital , Southern Medical University , Guangzhou 510515 , China ( Xiao , Zhang , Zhu , Hu , Liu ) Department of Infectious Diseases , Nanfang Hospital , Southern Medical University , Guangzhou ) : 102880 . Available from : http : / / www . journals . elsevier . com / ebiomedicine / 168 . Xu J , Yang X , Yang L , Zou X , Wang Y , Wu Y , et al . Clinical course and predictors of 60 - day mortality in 239 critically ill patients with COVID - 19 : a multicenter retrospective study from Wuhan , China . Crit Care Lond Engl . 2020 ; 24 ( 1 ) : 394 . 169 . Xu R . , Hou K . , Zhang K . , Xu H . , Zhang N . , Fu H . , et al . Performance of Two Risk - Stratification Models in Hospitalized Patients With Coronavirus Disease . Front Med [ Internet ] . 2020 ; 7 ( ( Xu , Zhang , Xu , Fu , Xie , Sun , Wen , Liu , Guo ) Key Laboratory of Birth Defects and Related Diseases of Women and Children of Ministry of Education , Department of Radiology , West China Second University Hospital , Sichuan University , Chengdu , China ( Hou , Zhang ) : 518 . Available from : http : / / journal . frontiersin . org / journal / medicine 170 . Xu W , Sun N - N , Gao H - N , Chen Z - Y , Yang Y , Ju B , et al . Risk factors analysis of COVID - 19 patients with ARDS and prediction based on machine learning . Sci Rep . 2021 ; 11 ( 1 ) : 2933 . 171 . Yang X , Yu Y , Xu J , Shu H , Xia J , Liu H , et al . Clinical course and outcomes of critically ill patients with SARS - CoV - 2 pneumonia in Wuhan , China : a single - centered , retrospective , observational study . Lancet Respir Med [ Internet ] . 2020 Feb [ cited 2020 Apr 23 ] ; S2213260020300795 . Available from : https : / / linkinghub . elsevier . com / retrieve / pii / S2213260020300795 172 . Yao T . , Gao Y . , Cui Q . , Peng B . , Chen Y . , Li J . , et al . Clinical characteristics of a group of deaths with COVID - 19 pneumonia in Wuhan , China : A retrospective case series . BMC Infect Dis [ Internet ] . 2020 ; 20 ( 1 ) : 695 . Available from : http : / / www . biomedcentral . com / bmcinfectdis / 173 . Yi H . , Lu F . , Jin X . , Chen R . , Liu B . , Dong X . , et al . Clinical characteristics and outcomes of coronavirus disease 2019 infections among diabetics : A retrospective and multicenter study in China . J Diabetes [ Internet ] . 2020 ; 12 ( 12 ) : 919 â 28 . Available from : http : / / onlinelibrary . wiley . com / journal / 10 . 1111 / ( ISSN ) 1753 - 0407 174 . Yu D . , Ininbergs K . , Hedman K . , Giske C . G . , Stralin K . , Ozenci V . Low prevalence of bloodstream infection and high blood culture contamination rates in patients with COVID - 19 . PLoS ONE [ Internet ] . 2020 ; 15 ( 11 November ) : e0242533 . Available from : https : / / journals . plos . org / plosone / article / file ? id = 10 . 1371 / journal . pone . 0242533 & type = printable J o u r n a l P r e - p r o o f 40 175 . Yu Y . , Xu D . , Fu S . , Zhang J . , Yang X . , Xu L . , et al . Patients with COVID - 19 in 19 ICUs in Wuhan , China : A cross - sectional study . Crit Care [ Internet ] . 2020 ; 24 ( 1 ) : 219 . Available from : http : / / ccforum . com / content / 17 176 . Zachariah P , Johnson CL , Halabi KC , Ahn D , Sen AI , Fischer A , et al . Epidemiology , Clinical Features , and Disease Severity in Patients With Coronavirus Disease 2019 ( COVID - 19 ) in a Childrenâs Hospital in New York City , New York . Zucker JE AK Foca MD , Shah SS , Cheng J , Lee J , Hooe B , Carlin RF , Kingery F , Charnay A , Paik S , Lakhaney D , editor . JAMA Pediatr . 2020 ; ( 101589544 ) : e202430 . 177 . Zangrillo A . , Beretta L . , Scandroglio A . M . , Monti G . , Fominskiy E . , Colombo S . , et al . Characteristics , treatment , outcomes and cause of death of invasively ventilated patients with COVID - 19 ARDS in Milan , Italy . Crit Care Resusc J Australas Acad Crit Care Med . 2020 ; ( ( Zangrillo , Beretta , Scandroglio , Monti , Fominskiy , Colombo , Morselli , Belletti , Silvani , Crivellari , Monaco , Azzolini , Reineke , Nardelli , Sartorelli , Votta , Ruggeri , Landoni ) Department of Anesthesia and Intensive Care , IRCCS San Raffaele Scientific Inst ) . 178 . Zeng Q . - L . , Li G . - M . , Ji F . , Ma S . - H . , Zhang G . - F . , Xu J . - H . , et al . Clinical course and treatment efficacy of COVID - 19 near Hubei Province , China : A multicentre , retrospective study . Transbound Emerg Dis [ Internet ] . 2020 ; 67 ( 6 ) : 2971 â 82 . Available from : http : / / onlinelibrary . wiley . com / journal / 10 . 1111 / ( ISSN ) 1865 - 1682 179 . Zhang G , Hu C , Luo L , Fang F , Chen Y , Li J , et al . Clinical features and short - term outcomes of 221 patients with COVID - 19 in Wuhan , China . J Clin Virol Off Publ Pan Am Soc Clin Virol . 2020 ; 127 ( cx0 , 9815671 ) : 104364 . 180 . Zhang J , Kong W , Xia P , Xu Y , Li L , Li Q , et al . Impaired Fasting Glucose and Diabetes Are Related to Higher Risks of Complications and Mortality Among Patients With Coronavirus Disease 2019 . Front Endocrinol . 2020 ; 11 ( 101555782 ) : 525 . 181 . Zhang Y . , Xiao L . - S . , Li P . , Hu C . , Zhang W . - F . , Sun Q . - C . , et al . Clinical Characteristics of Patients With Progressive and Non - progressive Coronavirus Disease 2019 : Evidence From 365 Hospitalised Patients in Honghu and Nanchang , China . Front Med [ Internet ] . 2020 ; 7 ( ( Zhang , Liu ) Department of Medical Quality Management , Nanfang Hospital , Southern Medical University , Guangzhou , China ( Zhang , Xiao , Zhu , Hu , Sun , Shen , Liu , Zhang , Zeng , Liu ) Department of Infectious Diseases , Nanfang Hospital , Southern Medical University ) : 556818 . Available from : http : / / journal . frontiersin . org / journal / medicine 182 . Zhang L . , Fan T . , Yang S . , Feng H . , Hao B . , Lu Z . , et al . Comparison of clinical characteristics of COVID - 19 between elderly patients and young patients : a study based on a 28 - day follow - up . Aging . 2020 ; 12 ( 20 ) : 19898 â 910 . 183 . Zhang P . , He Z . , Yu G . , Peng D . , Feng Y . , Ling J . , et al . The modified NUTRIC score can be used for nutritional risk assessment as well as prognosis prediction in critically ill COVID - 19 patients . Clin Nutr [ Internet ] . 2020 ; ( ( Zhang ) Department of Neurology , Tongji Hospital , Tongji Medical College , Huazhong University of Science and Technology , Wuhan , China ( He , Yu , Peng , Feng , Ling , Wang , Li , Bian ) Department of Emergency , Intensive Care Unit , Tongji Hospital , Tongji Medical C ) . Available from : http : / / www . elsevier - international . com / journals / clnu / J o u r n a l P r e - p r o o f 41 184 . Zhao K . , Li R . , Wu X . , Zhao Y . , Wang T . , Zheng Z . , et al . Clinical features in 52 patients with COVID - 19 who have increased leukocyte count : a retrospective analysis . Eur J Clin Microbiol Infect Dis [ Internet ] . 2020 ; 39 ( 12 ) : 2279 â 87 . Available from : http : / / link . springer . de / link / service / journals / 10096 / index . htm 185 . Zhou F , Yu T , Du R , Fan G , Liu Y , Liu Z , et al . Clinical course and risk factors for mortality of adult inpatients with COVID - 19 in Wuhan , China : a retrospective cohort study . The Lancet [ Internet ] . 2020 Mar [ cited 2020 Apr 6 ] ; 395 ( 10229 ) : 1054 â 62 . Available from : https : / / linkinghub . elsevier . com / retrieve / pii / S0140673620305663 186 . Klein EY , Monteforte B , Gupta A , Jiang W , May L , Hsieh Y - H , et al . The frequency of influenza and bacterial coinfection : a systematic review and meta - analysis . Influenza Other Respir Viruses [ Internet ] . 2016 Sep [ cited 2020 Apr 21 ] ; 10 ( 5 ) : 394 â 403 . Available from : http : / / doi . wiley . com / 10 . 1111 / irv . 12398 187 . MacIntyre CR , Chughtai AA , Barnes M , Ridda I , Seale H , Toms R , et al . The role of pneumonia and secondary bacterial infection in fatal and serious outcomes of pandemic influenza a ( H1N1 ) pdm09 . BMC Infect Dis [ Internet ] . 2018 Dec [ cited 2020 May 5 ] ; 18 ( 1 ) : 637 . Available from : https : / / bmcinfectdis . biomedcentral . com / articles / 10 . 1186 / s12879 - 018 - 3548 - 0 188 . RECOVERY Collaborative Group . Tocilizumab in patients admitted to hospital with COVID - 19 ( RECOVERY ) : a randomised , controlled , open - label , platform trial . Lancet Lond Engl . 2021 May 1 ; 397 ( 10285 ) : 1637 â 45 . 189 . The RECOVERY Collaborative Group . Dexamethasone in Hospitalized Patients with Covid - 19 . N Engl J Med [ Internet ] . 2021 Feb 25 [ cited 2021 Aug 6 ] ; 384 ( 8 ) : 693 â 704 . Available from : http : / / www . nejm . org / doi / 10 . 1056 / NEJMoa2021436 190 . The REMAP - CAP Investigators . Interleukin - 6 Receptor Antagonists in Critically Ill Patients with Covid - 19 . N Engl J Med [ Internet ] . 2021 Apr 22 [ cited 2021 Aug 6 ] ; 384 ( 16 ) : 1491 â 502 . Available from : http : / / www . nejm . org / doi / 10 . 1056 / NEJMoa2100433 191 . The WHO Rapid Evidence Appraisal for COVID - 19 Therapies ( REACT ) Working Group , Sterne JAC , Murthy S , Diaz JV , Slutsky AS , Villar J , et al . Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID - 19 : A Meta - analysis . JAMA [ Internet ] . 2020 Oct 6 [ cited 2021 Aug 6 ] ; 324 ( 13 ) : 1330 . Available from : https : / / jamanetwork . com / journals / jama / fullarticle / 2770279 192 . Osuchowski MF , Winkler MS , Skirecki T , Cajander S , Shankar - Hari M , Lachmann G , et al . The COVID - 19 puzzle : deciphering pathophysiology and phenotypes of a new disease entity . Lancet Respir Med [ Internet ] . 2021 Jun [ cited 2021 Aug 29 ] ; 9 ( 6 ) : 622 â 42 . Available from : https : / / linkinghub . elsevier . com / retrieve / pii / S2213260021002186 193 . Luyt C - E , HÃ©kimian G , Koulenti D , Chastre J . Microbial cause of ICU - acquired pneumonia : hospital - acquired pneumonia versus ventilator - associated pneumonia . Curr Opin Crit Care [ Internet ] . 2018 Oct [ cited 2021 Aug 6 ] ; 24 ( 5 ) : 332 â 8 . Available from : http : / / journals . lww . com / 00075198 - 201810000 - 00004 J o u r n a l P r e - p r o o f 42 194 . Dudeck MA , Allen - Bridson K , Edwards JR . Pathogens Associated With Repeat Versus Single Central - Line â Associated Bloodstream Infections , Acute - Care Hospitals , NHSN . Infect Control Hosp Epidemiol [ Internet ] . 2020 Oct [ cited 2021 Aug 6 ] ; 41 ( S1 ) : s343 â 4 . Available from : https : / / www . cambridge . org / core / product / identifier / S0899823X20009563 / type / journal _ article 195 . National Institute for Health and Care Excellence ( NICE ) . COVID - 19 rapid guideline : antibiotics for pneumonia in adults in hospital [ Internet ] . 2020 . Available from : https : / / www . nice . org . uk / guidance / ng173 / chapter / 4 - Assessing - the - ongoing - need - for - antibiotics 196 . COVID - 19 Treatment Guidelines Panel . COVID - 19 Treatment Guidelines [ Internet ] . National Institutes of Health ; Available from : https : / / www . covid19treatmentguidelines . nih . gov / 197 . World Health Organization . Clinical Management of COVID - 19 Interim Guidance [ Internet ] . Geneva , Switzerland : World Health Organization ; Available from : https : / / www . who . int / publications - detail / clinical - management - of - severe - acute - respiratory - infection - when - novel - coronavirus - ( ncov ) - infection - is - suspected 198 . Sieswerda E , de Boer MGJ , Bonten MMJ , Boersma WG , Jonkers RE , Aleva RM , et al . Recommendations for antibacterial therapy in adults with COVID - 19 â an evidence based guideline . Clin Microbiol Infect [ Internet ] . 2021 Jan [ cited 2021 Jan 17 ] ; 27 ( 1 ) : 61 â 6 . Available from : https : / / linkinghub . elsevier . com / retrieve / pii / S1198743X20305942 199 . Feldman C , Anderson R . The role of co - infections and secondary infections in patients with COVID - 19 . Pneumonia [ Internet ] . 2021 Dec [ cited 2021 Aug 6 ] ; 13 ( 1 ) : 5 . Available from : https : / / pneumonia . biomedcentral . com / articles / 10 . 1186 / s41479 - 021 - 00083 - w J o u r n a l P r e - p r o o f 56 , 767 studies identified via database search 33 , 345 studies screened 24 , 322 duplicates removed 1 , 798 studies assessed for eligibility 31 , 547 studies irrelevant 1 , 627 studies excluded â¢ 1 , 186 bacterial infection data not provided â¢ 162 commentary or editorial â¢ 100 less than 50 patients â¢ 62 insufficient information â¢ 40 includes non - confirmed SARS - CoV - 2 â¢ 36 review article â¢ 12 co - infection measured by throat swab â¢ 11 co - infection measured by serology â¢ 7 guideline â¢ 9 pre - print / unpublished â¢ 2 full - text not available 171 studies included J o u r n a l P r e - p r o o f Acinetobacter ( 23 ) CNST ( 217 ) Chlamydia ( 5 ) Enterococcus ( 65 ) Enterobacter ( 42 ) S . aureus ( 332 ) Escherichia ( 99 ) S . pneumoniae ( 40 ) Haemophilus ( 38 ) Other Streptococcus ( 69 ) Klebsiella ( 113 ) Other Gram positive ( 49 ) Legionella ( 2 ) Mycoplasma ( 25 ) Proteus ( 7 ) Pseudomonas ( 90 ) Other organisms ( 45 ) Serratia ( 9 ) Stenotrophomonas ( 8 ) Other Gram negative ( 41 ) Co - Infection ( n = 1 , 319 organisms ) Acinetobacter ( 123 ) CNST ( 184 ) Chlamydia ( 38 ) Enterococcus ( 159 ) Enterobacter ( 73 ) S . aureus ( 315 ) Escherichia ( 157 ) S . pneumoniae ( 183 ) Haemophilus ( 129 ) Other Streptococcus ( 37 ) Klebsiella ( 233 ) Other Gram positive ( 29 ) Legionella ( 1 ) Mycoplasma ( 42 ) Proteus ( 14 ) Pseudomonas ( 198 ) Other organisms ( 2 ) Serratia ( 23 ) Stenotrophomonas ( 41 ) Other Gram negative ( 35 ) Secondary Infection ( n = 2 , 016 organisms ) 21 - 25 % 16 - 20 % 11 - 15 % 6 - 10 % 1 - 5 % 0 % J o u r n a l P r e - p r o o f Co - Infection Secondary Infection J o u r n a l P r e - p r o o f Co - Infection Secondary Infection J o u r n a l P r e - p r o o f